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ABSTRACT 
 Elderly people living in long-term care (LTC) are at risk for malnutrition. Those 
who consume a pureed diet may be particularly at risk because of the food restrictions 
required on a pureed diet. Fortification of pureed foods with micronutrients may be an 
effective technique to treat malnutrition. The purpose of this study was to develop 
fortified pureed foods to incorporate into a menu at a LTC facility to assess if nutrient 
intakes and serum vitamin levels increased. 
 Fortification levels were determined using a combination of two techniques: the 
Dietary Reference Intakes report on planning formula, Estimated Average Requirement 
plus two standard deviations of intake; and Health Canada’s method of using a defined 
nutrient contribution to the total daily intake. Fortification levels for 11 vitamins and 9 
minerals were determined, which allowed for formulation of a vitamin/mineral mix and 
a vitamin-only mix. Seven pureed foods were fortified and triangle sensory tests were 
performed to determine whether fortification changed the flavour of the foods. Panelists 
were able to discriminate between the unfortified and vitamin/mineral fortified mix 
samples (P > 0.05). When the vitamin-only fortified foods were subjected to the triangle 
test, the panelists were unable to detect a difference (P < 0.05).  
 Four vitamin-fortified foods per day were incorporated into the pureed menu at a 
LTC facility. Nutrient intakes (n = 10) and serum vitamin B12, folate, and 25-
hydroxyvitamin D levels (n = 11) were analyzed at baseline and 8 weeks after the 
intervention. Nutrient intakes increased after the intervention for all vitamins assessed  
(P < 0.01). Serum 25-hydroxyvitamin D and folate levels increased from 41 ± 21 
nmol/L and 10.7 ± 4.9 nmol/L at baseline to 66 ± 11 nmol/L and 25.2 ± 6.4 nmol/L after 
the intervention (P < 0.01). Serum vitamin B12 levels did not change (P > 0.05). 
iii 
 The development of acceptable vitamin-fortified pureed foods is feasible and 
fortified pureed foods are an effective way to increase the nutritional status of LTC 
residents.
iv 
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CHAPTER 1 
INTRODUCTION
1.1 BACKGROUND 
 The prevalence of malnutrition in the elderly is high, especially among those 
living in institutional settings (Keller, 1993). The consequences of malnutrition include 
frailty, poor immunity, and decreased functional ability and quality of life (Bartali et al., 
2006; Keller, 2004; Lesourd, 2004). Long-term care (LTC) residents with dysphagia 
who are required to consume a pureed diet to facilitate swallowing may be at high risk 
for malnutrition because of the food restrictions required on a pureed diet.  
 Several studies have shown that energy, macronutrient, and micronutrient intakes 
are inadequate in LTC residents. Odlund Olin, Koochek, Ljunggvist, and Cederholm 
(2005) compared actual energy intakes to estimated energy requirements in LTC 
residents aged 79-90 years and found that intakes were significantly below requirements. 
In a study of LTC residents ≥ 65 years of age, Lengyel, Whiting, and Zello (In press) 
found low intakes of folate, magnesium, zinc, vitamin E, vitamin B6, calcium, vitamin 
D, and dietary fibre. R. M. Johnson, Smiciklas-Wright, Soucy, and Rizzo (1995) found 
that women living in a nursing home and consuming either a regular or pureed diet had 
inadequate intakes of iron, zinc, calcium, and vitamin D. 
 Although intakes of many vitamins and minerals are low in this population, three 
vitamins of primary concern are vitamin D, vitamin B12, and folate. The elderly are at 
increased risk for vitamin D deficiency due to lack of sun exposure, decreased ability to 
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synthesize vitamin D endogenously when the skin is exposed to sunlight, and the limited 
number of dietary sources of the vitamin (Armas, Hollis, & Heaney, 2004; Gloth, Smith, 
Hollis, & Tobin, 1995; MacLaughlin & Holick, 1985). Vitamin B12 is a concern for 
people over 50 years of age because of the increased prevalence of atrophic gastritis 
which results in decreased absorption of the vitamin (Andres et al., 2004). Folate is a 
concern because people consuming a pureed diet may have difficulty consuming enough 
folate-rich foods to meet their requirements since foods that are high in folate, such as 
leafy green vegetables and folic acid-fortified grain products, are difficult to make into a 
pureed consistency (Adolphe, Dahl, Whiting, & Tyler, 2006).  
 There is currently no consensus on the best way to treat micronutrient (vitamin 
and mineral) malnutrition among LTC residents consuming a pureed diet. Food 
fortification with vitamins and/or minerals is a possible solution but has not been studied 
in this population. Health Canada’s fortification laws are currently under revision and 
may provide an opportunity for food manufacturers to develop fortified pureed foods 
under the category “special purpose foods” (Health Canada, 2005). However, there is 
currently no universally accepted method to determine fortification levels. Therefore, 
investigation into the appropriate methods to determine fortification levels needs to be 
completed. Subsequently, it needs to be determined whether the newly developed 
fortified foods are successful at improving the micronutrient status of those consuming 
them. 
 
1.2 PURPOSE 
 A variety of methods are currently used to help prevent and correct malnutrition 
in LTC residents consuming a pureed diet. These methods include serving nutrient-
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dense meals, increasing meal frequency, and providing oral nutritional supplements. 
However, there is evidence that these techniques may not be effective in achieving 
improved nutritional status (Milne, Avenell, & Potter, 2006; Taylor & Barr, 2006). Food 
fortification with micronutrients is a cost-effective way to provide nutrient-dense foods 
to a large number of people. Using fortified foods to improve the nutritional status of 
LTC residents consuming a pureed diet has the potential to improve their health status 
and quality of life. However, evidence is still needed as to how to determine appropriate 
fortification levels and whether or not fortification is feasible and effective in this 
population.  
 
1.3 OBJECTIVES 
 The objectives of the study are as follows: 
1. To determine appropriate micronutrient fortification levels for pureed foods 
for consumption by LTC residents. 
2. To assess if fortification results in detectable flavour changes. 
3. To incorporate nutrient-dense fortified pureed foods into the menu at a LTC 
facility. 
4. To determine if the fortified pureed foods increase the nutrient intakes of the 
residents consuming them. 
5. To determine the effect of fortified pureed foods on serum levels of vitamin 
B12, 25-hydroxyvitamin D, and folate of long-term care residents. 
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1.4 HYPOTHESES 
 The hypotheses of the study are as follows: 
1. By using the Dietary Reference Intakes menu planning methods and Health 
Canada fortification guidelines, fortification levels can be determined that 
will result in adequate micronutrient intakes of LTC residents consuming a 
pureed diet, but prevent excessive intakes. 
2. The addition of micronutrients to fortified pureed foods will increase the 
nutrient intakes of LTC residents prescribed a pureed diet. 
3. The concentrations of serum vitamin B12, folate, and 25-hydroxyvitamin D 
will increase in the residents consuming the fortified pureed diet.
5 
CHAPTER 2 
LITERATURE REVIEW
2.1 NUTRITION AND AGING 
2.1.1 Dietary Recommendations for Adults over 50 
 The Dietary Reference Intakes (DRI) provide nutrient reference values for 
healthy individuals and are categorized by age and gender. As shown in Table 2.1, the 
Estimated Average Requirement (EAR), Recommended Dietary Allowance (RDA) 
and/or Adequate Intake (AI) for most nutrients do not change for younger adults  
(31-50 y) compared to older adults (≥ 51 y) (Otten, Pitzi Hellwig, & Meyers, 2006). 
However, there are a few nutrients for which the recommendations increase or decrease 
between the two age groups, which are highlighted in Table 2.1.  
According to the DRI report on vitamin B6, adults over 50 appear to have a 
slightly higher requirement for the vitamin compared to younger adults, although the 
report states that there has been only a limited number of studies that examined vitamin 
B6 requirements in older adults (Institute of Medicine, 1998). The AI for calcium is 
higher in the older age group based on data that demonstrated a positive reduction in 
bone loss with calcium intakes above 1,000 mg/day and because calcium absorption 
declines with age (Institute of Medicine, 1997). Bone loss was used as an indicator of 
adequacy for vitamin D in the 51-70 age group and the recommendation was increased  
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Table 2.1 Comparison of EAR and RDA values for adults 31-50 y and ≥ 51 y. 
 
              EAR(AI)1                 RDA1 Nutrient 
31-50 y ≥ 51 y 31-50 y ≥ 51 y 
Vitamin A (µg RAE) 
Males 
Females 
 
625 
500 
 
625 
500 
 
900 
700 
 
900 
700 
Vitamin B6 (mg) 
Males 
Females 
 
1.1 
1.1 
 
1.4 
1.3 
 
1.3 
1.3 
 
1.7 
1.5 
Vitamin B12 (µg) 2.0 2.0 2.4 2.4 
Biotin (µg) (30) (30) - - 
Vitamin C (mg) 
Males 
Females 
 
75 
60 
 
75 
60 
 
90 
75 
 
90 
75 
Vitamin D (µg) (5) (10) 51-70 y 
(15) >70 y 
- - 
Vitamin E (mg) 12 12 15 15 
Folate (µg) 320 320 400 400 
Vitamin K (µg) 
Males 
Females 
 
(120) 
(90) 
 
(120) 
(90) 
 
- 
 
- 
Niacin (mg) 
Males 
Females 
 
12 
11 
 
12 
11 
 
16 
14 
 
16 
14 
Pantothenic Acid (mg) (5) (5)   
Riboflavin (mg) 
Males 
Females 
 
1.1 
0.9 
 
1.1 
0.9 
 
1.3 
1.1 
 
1.3 
1.1 
Thiamin (mg) 
Males 
Females 
 
1.0 
0.9 
 
1.0 
0.9 
 
1.2 
1.1 
 
1.2 
1.1 
Calcium (mg) (1000) (1200)   
Chromium (µg) 
Males 
Females 
 
(35) 
(25) 
 
(30) 
(20) 
  
Copper (µg) 700 700 900 900 
Iodine (µg) 95 95 150 150 
Iron (mg) 
Males 
Females 
 
6.0 
8.1 
 
6.0 
5.0 
 
8 
18 
 
8 
8 
Magnesium (mg) 350 350 420 420 
Manganese (mg) (2.3) (2.3) - - 
Molybdenum (µg) 34 34 45 45 
Phosphorus (mg) 580 580 700 700 
Potassium (g) (4.7) (4.7) - - 
Selenium (µg) 45 45 55 55 
Zinc (mg) 9.4 9.4 11 11 
1Value shown is that for males and females unless otherwise indicated. 
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from 5 µg/day to 10 µg/day for this age group in order to prevent bone loss (Institute of 
Medicine, 1997). This recommendation was further increased to 15 µg/day for the >70 
age group because of the evidence that serum 25-hydroxyvitamin D levels decrease and 
skeletal fractures increase in people over 70 (Institute of Medicine, 1997). The 
recommendation for chromium is slightly lower for older adults based on extrapolation 
from data from the younger age group. The level was calculated based on a chromium 
intake per 1,000 kcal which results in a lower value for older adults who on average 
consume less food (Institute of Medicine, 2001). Iron recommendations decrease for 
women over 50 due to menopause when women no longer lose iron due to menstruation 
(Institute of Medicine, 2001).  
 
2.1.2 Malnutrition in Long-Term Care 
 Malnutrition is a major concern in LTC and numerous studies have shown that 
energy, macronutrient, and micronutrient (i.e. vitamin and mineral) intakes are 
inadequate in this population (Akner & Floistrup, 2003; Odlund Olin, Koochek, 
Ljunggvist, & Cederholm, 2005). The prevalence of malnutrition in LTC residents has 
been estimated to be as high as 85% (Keller, 1993). However, it is difficult to accurately 
determine the prevalence of malnutrition due to differences in how malnutrition is 
defined and measured. There are numerous criteria used to define malnutrition, 
including inadequate nutritional status, undernourishment characterized by insufficient 
dietary intake, poor appetite, muscle wasting, biochemical measurements such as serum 
albumin, and weight loss (Chen, Schilling, & Lyder, 2001). Malnutrition can also be 
classified based on its severity. Keller (1993) found that severe undernutrition was 
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present in 18% of elderly LTC residents and mild to moderate undernutrition was 
present in 27%.  
 As shown in Table 2.2, many of the risk factors for malnutrition are common 
among elderly people, especially in those living in LTC facilities. These factors can 
generally be classified into two groups: those that cause inadequate intake and those that 
increase nutrient requirements (Abbasi & Rudman, 1994). The consequences of 
malnutrition can be detrimental and improving the nutritional status of the elderly has 
the potential to make a tremendous impact on their overall health.  
 
Table 2.2 Risk factors for and consequences of malnutrition. 
 
Risk Factors for Malnutrition1 Consequences of Malnutrition2 
Age 
Female gender 
Low activity level 
Poor communication 
Medication use 
Poor oral intake 
Eating dependency 
Chewing and swallowing difficulty 
Decubiti 
History of hip fracture 
Illness/infection 
Impaired cognition 
Sarcopenia 
Impaired muscle function 
Decreased bone mass 
Immune dysfunction 
Anemia 
Altered drug metabolism 
1(Abbasi & Rudman, 1994; Fiatarone Singh, Bernstein, Ryan, O'Neill, Clements, & Evans, 2000; Keller, 1993) 
2(Donini, Savina, & Cannella, 2003; Fiatarone Singh et al., 2000) 
 
 
The relationships between malnutrition, frailty, immunity, functional ability, and 
quality of life have been topics of recent interest. Frailty can be defined as an increased 
vulnerability to stressors and increased risk of adverse outcomes including disability and 
death (Ble et al., 2006). It appears that diet quality plays a role in muscle efficiency and 
that a low intake of nutrients is associated with frailty even independent of energy intake 
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(Bartali et al., 2006). Specifically, low levels of vitamins E, C, and D have been shown 
to be risk factors for frailty (Bartali et al., 2006; Ble et al., 2006). Frailty and immunity 
are interrelated because the decrease in food consumption that often accompanies the 
frailty state leads to a decline in nutritional status and decreased immune responses. Poor 
immune system functioning, which has been thought to be a consequence of aging, may 
be due to low micronutrient status (Lesourd, 2004). Frailty and poor immune function 
also affect functional ability and quality of life because if the diet is deficient in 
nutrients, chronic diseases can develop or be aggravated (Keller, 2004). By improving 
nutritional status, functional ability can also be enhanced (Hickson & Frost, 2004) 
Micronutrient malnutrition is an important concern among the elderly because 
over time insufficient status for one or more micronutrients may contribute to the 
development of disease (Brouwer, Welten, Reijngoud, van Doormaal, & Muskiet, 1998). 
Increasing age is a strong risk factor for poor nutritional status and elderly persons are at 
higher risk of vitamin deficiencies than younger adults (Forster & Gariballa, 2005; K. A. 
Johnson, Bernard, & Funderburg, 2002). A summary of the Canadian provincial 
nutrition surveys from the 1990’s found that nutrient intakes decreased with age among 
free-living individuals (Dolega-Cieszkowski, Bobyn, & Whiting, 2006). This decrease 
may be even more apparent in LTC facilities where people often have concomitant 
factors that impact nutrient intake.  
Recent data collected locally in LTC facilities in the Saskatoon Health Region 
suggests a high prevalence of inadequacy for folate, magnesium, zinc, vitamin E, and 
vitamin B6 (Lengyel, Whiting, & Zello, In press). R. M. Johnson, Smiciklas-Wright, 
Soucy, and Rizzo (1995) found that women living in a nursing home and consuming 
either a regular or pureed diet had inadequate intakes of iron, zinc, calcium, and  
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vitamin D. A study by Rudman, Abbasi, Isaacson, and Karpiuk (1995) found that 88% 
of nursing home residents who were dependent on a caregiver for feeding had intakes 
for three or more nutrients that were below 50% of the RDA (this study was performed 
prior to the development of the Dietary Reference Intakes so prevalence of inadequacy 
was not determined). It can be difficult to recognize someone who is vitamin deficient 
because deficiencies are often disguised as skin, neurological, and gait abnormalities  
(K. A. Johnson, Bernard, & Funderburg, 2002). This is why it is so important to develop 
effective solutions to correct the high prevalence of micronutrient malnutrition in LTC. 
 
2.1.3 Dysphagia 
 Dysphagia, or difficulty with swallowing, is a common disorder among elderly 
people living in LTC facilities (Kayser-Jones & Pengilly, 1999; Keller, 1993; Wright, 
Cotter, Hickson, & Frost, 2005). Dysphagia can lead to other medical conditions, 
including dehydration, aspiration pneumonia, suffocation, and malnutrition (Kawashima, 
Motohashi, & Fujishima, 2004). Dysphagic residents are at high risk of malnutrition due 
to the dietary changes used to treat the condition as well as the underlying cause of the 
disorder, which includes stroke, dementia, neuromuscular diseases, and cancer (Wright 
et al., 2005). Dysphagic residents are usually unable to feed themselves which is a major 
risk factor for undernutrition in LTC facilities (Abbasi & Rudman, 1994).  
 The diets most often used to treat dysphagia are referred to as texture-modified 
diets, which include consistencies from soft to minced to pureed depending on the 
severity of the dysphagia. The energy and protein requirements of individuals receiving 
a texture-modified diet have been shown to be the same as the requirements of people 
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consuming a normal diet. However, inadequate intakes of energy and protein in texture-
modified diet groups can be large (Wright et al., 2005). 
 
2.1.4 Strategies Used to Treat Malnutrition in Long-Term Care Residents 
 Dietitians and other healthcare professionals use a number of techniques to 
improve the nutrient and energy intakes of malnourished individuals. However, 
traditional dietary intervention methods intended to improve the nutritional status of 
LTC residents with or without dysphagia are not necessarily evidence-based. Some of 
the strategies used to prevent or correct malnutrition in this vulnerable population are 
discussed below.  
Increased Meal Frequency: One technique used to improve an individual’s 
nutritional status is to offer small, frequent meals in order to minimize fatigue while 
eating. However, until recently, the effectiveness of this strategy to increase food intake 
had not been studied quantitatively. Taylor and Barr (2006) recently reported on a small 
(n = 31) cross-over study comparing whether or not a five-meal pattern versus a 
traditional three-meal pattern improves energy intake among elderly LTC residents with 
dysphagia. Participants were randomly assigned to one of two meal pattern groups to 
receive either the three- or five- meal pattern menu for four days. Four weeks later, the 
groups were switched to the other meal pattern for four days. The three- and five-meal 
menus each provided approximately 1650 kcal/day and were of pureed or minced 
consistency. The investigators found that average energy intakes were similar between 
the three- and five-meal patterns (1,325 ± 207 kcal/day vs. 1,342 ± 177 kcal/day, 
respectively; P = 0.565) and that approximately 80% of the energy served for both meal 
patterns was consumed. The five-meal pattern also created some practical challenges for 
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the care staff, as many of the participants required feeding assistance. The researchers 
concluded that serving small, frequent meals did not improve energy intakes and that 
other nutrition intervention strategies need to be considered to appropriately nourish 
elderly people with dysphagia.  
Increased Meal Energy Density: There is some evidence that the frequency of the 
meals may not matter as much as the meal energy density when the goal is to increase 
energy intakes. A study by Lorefalt, Wissing, and Unosson (2005) found that smaller 
energy- and protein-enriched meals improved energy intakes by 37% compared with the 
standard hospital menu in ten elderly patients consuming a regular texture diet at a 
geriatric rehabilitation ward. The first week after inclusion, the patients were offered a 
three-day standard hospital menu and in the second week, a three-day energy- and 
protein-enriched menu. Both menus consisted of three meals and two snacks per day, but 
the energy- and protein-enriched menu used portion sizes equal to half the standard size 
and the protein and energy content corresponding to a whole portion size. This study, 
while small and only short-term, suggests that the energy density of meals is an 
important factor to increase intakes.  
The ways in which the menus where changed in each study may have contributed 
to the negative findings in the meal frequency study by Taylor and Barr (2006) and the 
positive findings in the energy density study by Lorefalt et al. (2005). The meal 
frequency study by Taylor & Barr simply redistributed the foods on the regular menu, 
while the energy density study by Lorefalt et al. used new menu items and enriched the 
foods with cream, butter, oils, and maize gruel. These changes would likely improve the 
palatability of the foods which can result in increased intakes. In addition, the energy 
density study by Lorefalt et al. did not use texture-modified foods, as did the food 
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frequency study by Taylor & Barr. It may be easier to make menu changes on a regular 
diet as there are fewer food restrictions than for a texture-modified diet.  
However, making menu changes to increase intakes on a texture-modified diet has 
also been shown to be successful when an effort is made to prepare appealing texture-
modified foods (Germain, Dufresne, & Gray-Donald, 2006). The study compared a 
newly developed dysphagia diet with a standard texture-modified diet. The dysphagia 
diet consisted of minced and pureed foods that were reshaped to look similar to regular 
texture foods. Compared to subjects consuming the standard texture-modified diet, the 
novel dysphagia diet was successful at increasing intakes of energy and several 
nutrients, including protein, magnesium, calcium, and vitamin D.  
Oral Nutritional Supplements: Another dietary intervention that is often 
recommended to improve energy, protein, and nutrient intakes of LTC residents is the 
provision of oral nutritional supplements. There has been a lack of consensus about 
whether or not oral liquid supplements are effective at maintaining or improving 
nutritional status in LTC. Milne (2006) systematically reviewed oral nutritional 
supplementation on clinical and nutritional outcomes of older people in the hospital, 
institutions and the community. Fifty-five trials involving 9187 subjects were reviewed 
and the evidence suggested that there may be fewer complications and lower mortality 
with supplementation for short-term hospital stays in individuals that were 
undernourished at baseline. There was little evidence to suggest that longer-term 
supplementation was effective, although most studies were “small or had short follow-
up times and used outcome assessors who knew which patients took supplements” 
(Milne, 2006). In addition, researchers have acknowledged that when a frail elderly 
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person is already malnourished, nutrition intervention alone may be too late and 
preventative strategies are needed to optimize nutritional status to minimize functional  
decline (Payette, Boutier, Coulombe, & Gray-Donald, 2002). Fiatarone Singh et al. 
(2000) were unable to increase energy and micronutrient status using oral liquid 
supplements after 10 weeks of supplementation despite high compliance of the frail, 
institutionalized elderly subjects. The researchers concluded that the subjects appeared 
to decrease their habitual food intake to compensate for the additional supplements. 
Furthermore, if usual foods are replaced with oral supplements, the overall acceptability 
of the diet and quality of life may decrease.  
Low consumption rates of oral liquid or pudding supplements may be a problem, 
resulting in little or no improvement in nutrient intakes and considerable wastage. 
Wright et al. (2005) studied hospital patients who consumed either a texture modified 
diet (n = 30) or a normal hospital diet (n = 25). Sixteen patients from the texture 
modified group were prescribed liquid supplements but only 11 consumed some or the 
entire supplement. In a study by Remsburg, Sobel, Cohen, Koch, and Radu (2001), an 
energy-dense oral liquid supplement was dispensed with the routine medication pass at a 
LTC facility. They found that 35% of the supplements were wasted during a three day 
observation period. Thus, oral liquid or pudding supplementation does not appear to be a 
very effective method of nutrition delivery, especially if it is uncertain whether or not 
the supplements actually maintain or improve nutritional status.  
Oral Micronutrient Supplements: Vitamin/mineral supplement pills are a possible 
solution to the high prevalence of micronutrient malnutrition in LTC. However, there are 
problems associated with the administration of these. It is difficult to have more than 
50% of the target population consume vitamin supplements (Oakley, 2004). Due to large 
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administrative costs, supplement programs are more expensive than alternatives, such as 
fortification (Oakley, 2004). In general, geriatricians do not like their patients to take 
extra medication unless the benefits are very clear (F. Anderson, 2005). de Jong, Chin, 
de Graaf, Hiddink, de Groot, and van Staveren (2001) argue that medicalization of the 
elderly by prescribing vitamin pills is not a favourable direction and simultaneous intake 
of vitamin/mineral supplements with medications could induce a negative drug-nutrient 
interaction.  
 
2.2 VITAMINS OF CONCERN IN THE ELDERLY POPULATION 
2.2.1 Overview 
 Long-term care residents with dysphagia have inadequate intakes of many 
micronutrients (Adolphe et al., 2006; Germain et al., 2006; R. M. Johnson et al., 1995; 
Lengyel et al., In press; Rudman et al., 1995). Energy intakes in this population tend to 
be low (< 1600 kcal/day) which makes it difficult to obtain adequate amounts of 
vitamins and minerals (American Dietetic Association, 2005). Although it is important 
to ensure sufficient intake of all micronutrients, three vitamins that are of particular 
concern for this population are vitamin D, vitamin B12, and folate. Elderly people living 
in LTC who have limited mobility are at increased risk of inadequate vitamin D status 
because they likely have limited sun exposure, and when their skin is exposed to sun, 
they may have a decreased ability to synthesize the vitamin in their skin (Lamberg-
Allardt, 1984). Therefore, dietary sources of vitamin D become an important means for 
this population to obtain the vitamin, but there are only a limited number of foods that 
contain vitamin D. Vitamin B12 is a concern because of the increased prevalence of 
atrophic gastritis in the elderly which inhibits absorption of naturally-occurring  
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vitamin B12 from foods (Andres et al., 2004). Folate intake may be limited for people 
consuming a pureed diet since high folate foods, such as folic acid fortified grains and 
leafy green vegetables, are difficult to make into the appropriate pureed consistency. 
 
2.2.2 Vitamin D 
 2.2.2.1 Metabolism 
 Vitamin D, or calciferol, is likely best known for its role in bone health by aiding 
in the absorption of calcium and phosphorus, thus maintaining normal serum levels of 
these minerals (Otten et al., 2006). Vitamin D is also involved in cellular metabolism 
through anti-proliferation and pro-differentiation actions (Otten et al., 2006). Serum 25-
hydroxyvitamin D, or 25(OH)D, is the best indicator used to assess vitamin D status 
because it represents the summation of vitamin D from cutaneous synthesis and dietary 
intake of vitamin D2 and D3 (Institute of Medicine, 1997).  
Vitamin D is fat-soluble and occurs in many forms. Vitamin D2 (ergocalciferol) 
and vitamin D3 (cholecalciferol) are the two dietary forms and are both similarly 
metabolized. However, vitamin D3 has been shown to maintain serum 25(OH)D levels 
to a greater degree and is three to ten times more potent than vitamin D2 (Armas et al., 
2004). Vitamin D2 and vitamin D3 appear to create similar initial increases in serum 
25(OH)D concentrations, but vitamin D3 seems to maintain levels for substantially 
longer (Armas et al., 2004; J. L. Johnson, Mistry, Vukovich, Hogie-Lorenzen, Hollis, & 
Specker, 2005). Vitamin D2 is derived from ergosterol in yeast and plants and vitamin 
D3 originates from 7-dehydrocholesterol when it is synthesized in the skin (Otten et al., 
2006). In the liver, vitamin D is hydroxylated to 25-hydroxyvitamin D which then enters 
circulation and can be used as an indicator of vitamin D status. The biologically active 
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hormone form of vitamin D is 1,25-dihydroxyvitamin D which is formed by 
hydroxylation of 25-hydroxyvitamin D in the kidney. This conversion is tightly 
regulated by parathyroid hormone in response to serum calcium and phosphorus levels 
(Otten et al., 2006). Serum calcium and phosphorus levels are regulated by 1,25-
dihydroxyvitamin D which increases intestinal absorption of both minerals, increases 
calcium and phosphate resorption from bone, and reduces calcium loss in the urine 
(Mahan & Escott-Stump, 2004). 
Vitamin D is obtained through synthesis in the skin from exposure to ultraviolet B 
rays from the sun or through dietary intake. Endogenous synthesis of vitamin D in the 
skin through sunlight exposure is limited in northern climates. During the winter months 
in Canada, the angle at which the sun’s rays enter the earth’s atmosphere does not allow 
for vitamin D synthesis (Holick, 2004). There are very few food sources of vitamin D. 
Naturally-occurring food sources of vitamin D are limited to fatty fish, some fish liver 
oils, and eggs from hens who were fed vitamin D (Institute of Medicine, 1997). Foods in 
Canada that are fortified with vitamin D include milk and margarine. Vitamin D can also 
be obtained with supplements and can be given in smaller daily doses of 20 – 25 µg 
(800-1000 IU), in larger weekly doses of 125 µg (5000 IU), or in even larger doses 
every four to six months in amounts as much as 2500 µg (100,000 IU) (Utiger, 1998). 
2.2.2.2 Dosage 
Defining adequate vitamin D status depends on the criterion used. The AI for 
vitamin D set by the DRI committee was based on the amount needed in the absence of 
sun exposure to maintain adequate concentrations of serum 25(OH)D (Institute of 
Medicine, 1997). Historically, the criterion used to determine adequate vitamin D status 
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was the level of vitamin D needed to prevent the onset of rickets or osteomalacia, which 
appears to be a level of serum 25(OH)D below approximately 20-25 nmol/L  
(F. Anderson, 2005). This was the criterion that was used to set the AI but there was 
insufficient evidence to know what the dietary intake should be to achieve this level of 
serum 25(OH)D. Thus, the vitamin D intake of a group of apparently healthy adults was 
used and multiplied by 2 for uncertainty (Whiting & Calvo, 2005).  
Optimal serum 25(OH)D concentrations have been suggested to be ≥75 nmol/L 
(Bischoff-Ferrari, Giovannucci, Willett, Dietrich, & Dawson-Hughes, 2006; Heaney, 
2006). In order to prevent increased bone resorption, 25(OH)D levels need to be 
increased to about 50 nmol/L and it has been proposed that even higher levels (75-125 
nmol/L) are needed in order to prevent future disease onset (F. Anderson, 2005). Higher 
concentrations of 25(OH)D have been shown to have a positive benefit on calcium 
metabolism. Heaney, Dowell, Hale, and Bendich (2003) found that calcium absorption 
at a serum 25(OH)D concentration of 50 nmol/L was reduced compared to the amount 
of absorption at a concentration of 86 nmol/L. Dietary calcium intake may not need to 
be more than 800 mg/d if serum 25(OH)D concentrations are maintained above  
45 nmol/L (Steingrimsdottir, Gunnarsson, Indridason, Franzson, & Sigurdsson, 2005). 
An intake of 15 µg (600 IU) per day of vitamin D is needed to obtain a serum 
25(OH)D level of 50 nmol/L and at least 20-25 µg/day (800-1000 IU) is needed to reach 
75 nmol/L (Dawson-Hughes, Heaney, Holick, Lips, Meunier, & Vieth, 2005). A 12 
week intervention trial that included women aged 65-85 years examined the response of 
serum 25(OH)D to three doses (5, 10, 20 µg/day) of vitamin D3 (Viljakainen, Palssa, 
Karkkainen, Jakobsen, Lamberg-Allardt, 2006). An increase in serum 25(OH)D 
concentrations was observed after only two weeks in the supplemented groups compared 
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to placebo. Serum 25(OH)D levels reached a plateau at six weeks of supplementation 
and reached mean concentrations of 57.7 nmol/L, 59.9 nmol/L, and 70.9 nmol/L in the 
5, 10, and 20 µg vitamin D supplemented groups, respectively.  
A study that examined the dose response of serum 25(OH)D to vitamin D3 
suggests that if a 70 year old person receives 15 µg/day of oral vitamin D, the AI for this 
age group, and has no sunlight exposure, this amount is only sufficient to maintain a 
25(OH)D concentration of about 12.5 nmol/L (Heaney, Davies, Chen, Holick, & Barger-
Lux, 2003). Thus, the current AI for vitamin D is likely too low to maintain adequate 
levels of serum 25(OH)D. Heaney (2006) proposes that the UL of 50 µg/day (2000 IU) 
for adults is too low because the average daily requirement may be twice this amount. 
Healthy men may use as much as 75-125 µg (3000-5000 IU) of vitamin D3 per day, with 
>80% of their needs met during the winter from endogenously synthesized vitamin D 
produced from sunlight exposure during the summer (Heaney, Davies et al., 2003). 
Intakes above 50 µg/day appear to be safe as demonstrated in a study by Vieth, Chan, 
and MacFarlane (2001) in which a 100 µg/day (4000 IU) dosage of vitamin D3 increased 
25(OH)D levels into the high-normal range (mean ± SD, 96.4 ± 14.6 nmol/L). Table 2.3 
shows the classification of vitamin D status based on serum 25(OH)D levels and the 
amount of dietary vitamin D required to achieve these levels.  
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Table 2.3 Classification of vitamin D status by serum 25(OH)D and dietary vitamin 
D intake required to achieve serum 25(OH)D levels. 
 
Serum 25(OH)D Category Dietary Intake to 
Achieve Serum 
Level 
Notes 
< 20 nmol/L Vitamin D deficiency   
< 30 nmol/L Not at risk for clinical 
rickets or osteomalacia 
 Cut-off used for DRI 
recommendation 
30 – 75 nmol/L Vitamin D 
insufficiency defined as 
at risk for chronic 
conditions except 
rickets and 
osteomalacia 
5 – 20 µg/d Upper end of range 
deemed lowest 
25(OH)D for any 
health benefit 
75 – 80 nmol/L Threshold for vitamin 
D-dependent calcium 
absorption 
25 µg/d  
90 – 125 nmol/L Optimal status for some 
chronic conditions such 
as lower extremity 
function, periodontal 
disease, and fracture 
risk reduction 
100 µg/d  
>220 nmol/L Potential adverse 
effects are seen above 
this level 
250 µg/d  No adverse effects 
were detected 
Adapted from (Whiting, Calvo, & Stephensen, Submitted June 1, 2007) using references (Dawson-Hughes et al., 2005; Vieth, Chan, 
& MacFarlane, 2001; Viljakainen, 2006) 
 
2.2.2.3 Analysis 
Most analysis methods to measure serum 25(OH)D levels do not distinguish 
between 25(OH)D2 and 25(OH)D3, with the exception being a high performance liquid 
chromatography (HPLC) method (Gibson, 2005). In addition to HPLC, competitive 
protein-binding assays and radioimmunoassys are available to measure serum 25(OH)D 
(Gibson, 2005). Radioimmunoassays produce values that are about 30% lower than the 
competitive protein-binding assay which results in a cut-off value of 37.5 nmol/L for the 
radioimmunoassay method being comparable to a cut-off of 50 nmol/L for the 
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competitive protein-binding assay (Calvo & Whiting, 2003). Thus, the appropriate cut-
off value must be used based on the analysis method. Serum samples used to measure 
25(OH)D can be frozen, but repeated freezing and thawing should be avoided (Gibson, 
2005).  
2.2.2.4 Prevalence, Causes and Consequences of Deficiency 
The reported prevalence of vitamin D deficiency in the elderly depends partly on 
the cut-off values used to define deficiency. Regardless of the definition used, elderly 
people living in LTC facilities are at high risk for vitamin D deficiency and the 
prevalence of deficiency among institutionalized elderly is typically greater than the 
prevalence in elderly people living in the community. A study by Hirani and Primatesta 
(2005) reported that mean serum vitamin D levels for older adults (≥ 65 years) living in 
institutions were 38.1 nmol/L for men and 36.7 nmol/L for women, which was 
significantly lower than the values found for age-matched people living in private 
households (56.2 nmol/L for men and 48.4 nmol/L for women).  
Certain segments of the population, such as the elderly, may be at particular risk of 
not meeting their vitamin D requirements (American Dietetic Association, 2005). Long-
term care residents consuming a pureed diet are at increased risk of vitamin D deficiency 
for several reasons. Because of the limited endogenous vitamin D synthesis in northern 
climates and the limited number of dietary sources, Canadians are at risk of not 
receiving adequate amounts of vitamin D (Calvo & Whiting, 2003). The elderly LTC 
population may be at particular risk of limited sun exposure due to limited mobility. 
Lamberg-Allardt (1984) studied serum 25(OH)D levels in three groups of elderly people 
(65-80 years) over one year. Group 1 were long-stay geriatric patients, group 2 were 
residents in a seniors’ home, and group 3 were elderly people living in their own homes. 
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The study found that the serum 25(OH)D concentration in group 1 was the lowest of the 
three groups, group 2 was the next lowest, and group 3 had the highest concentrations. 
The investigators concluded that the low concentrations were due to both low dietary 
vitamin D intake and limited sunlight exposure (Lamberg-Allardt, 1984).  
Another factor that might contribute to low serum 25(OH)D levels is that when 
elderly people are exposed to sunlight they might have a reduced ability to synthesize 
vitamin D endogenously due to a decreased amount of 7-dehydrocholesterol in the skin 
(Armas et al., 2004; Gloth et al., 1995; MacLaughlin & Holick, 1985). It has also been 
suggested that intestinal absorption of vitamin D as well as metabolic activation of 
vitamin D in the liver and kidney may also diminish with age (L. T. Lee, Drake, & 
Kendler, 2002). However, this finding has recently been disputed (J. L. Johnson et al., 
2005).  
Vitamin D deficiency can lead to bone diseases such as rickets, osteomalacia, or 
osteoporosis (Otten et al., 2006). There is also increasing evidence of an association 
between vitamin D insufficiency and the risk of chronic diseases, including diabetes 
mellitus, cancer, autoimmune disorders, and osteoporosis (Calvo & Whiting, 2003; Natri 
et al., 2006). Vitamin D may improve lower extremity function, functional performance, 
reaction time and balance, which may have a positive effect on preventing falls 
(Bischoff-Ferrari et al., 2004; Bischoff et al., 2003; Dhesi et al., 2004; Jackson, Gaugris, 
Sen, & Hosking, 2007). Improving the vitamin D status of the elderly has the potential 
to decrease the risk of falls by 20% which may be mediated by the effect of vitamin D 
on postural or dynamic balance (Bischoff-Ferrari et al., 2006). Vitamin D has even been 
implicated in affecting mood and cognitive performance (Wilkins, Sheline, Roe, Birge, 
& Morris, 2006) and may be associated with seasonal epidemic influenza (Cannell et al., 
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2006). Recently, a four year randomized trial provided evidence of a relationship 
between cancer risk and vitamin D status (Lappe, Travers-Gustafson, Davies, Recker, & 
Heaney, 2007). In addition, vitamin D deficiency causes deep bone and muscle pain 
(Calvo & Whiting, 2003). Thus, inadequate vitamin D status can impact quality of life 
and ensuring adequate status in individuals with limited ability to communicate, such as 
elderly people with cognitive impairment, is essential to preventing unnecessary 
discomfort.  
 
2.2.2.5 Fortification 
Studies suggest that current fortification practices in Canada and the United States 
are not effective in preventing low vitamin D status, especially among vulnerable 
populations such as the elderly (Calvo, Whiting, & Barton, 2004). Milk is fortified with 
vitamin D at a level of 9.6 µg (385 IU) per liter (Calvo & Whiting, 2003). Since milk is 
one of the major dietary sources of vitamin D, elderly persons need to consume 
approximately 1.5 L/day of milk to meet the current AI of 15 µg (600 IU). Most elderly 
people are unlikely to consume such a large volume of milk and the fortification of 
additional foods would help the elderly meet their vitamin D requirement.  
A limited number of studies have investigated the effectiveness of fortifying 
various foods with vitamin D. Since vitamin D is fat-soluble, whether or not vitamin D 
is bioavailable from non-fat foods has been questioned. Tangpricha, Koutkia, Rieke, 
Chen, Perez, and Holick (2003) studied the bioavailability of vitamin D in two non-fat 
beverages, skim milk and orange juice. The study using milk compared the 
bioavailability of 625 µg (25,000 IU) vitamin D2 in whole milk, skim milk, and corn oil 
on toast. Each subject visited the research clinic on three different occasions, at least two 
24 
weeks apart, and the sequence in which each subject received the three fortified foods 
was randomized. Serum was obtained at 0, 2, 4, 8, 12, 48 and 72 hours after ingestion of 
the fortified food to measure serum levels of vitamin D. The results did not find a 
significant difference in serum vitamin D concentrations between the three groups which 
suggests that fat is not necessary for vitamin D to be absorbed. Since milk is not 
consumed by all individuals due to intolerance or taste preferences, the investigators 
then studied the feasibility of vitamin D fortification of orange juice (Tangpricha et al., 
2003). Two groups were included in the orange juice study: one group received 240 ml 
orange juice fortified with 350 mg calcium; and the other group received 240 ml orange 
juice fortified with 350 mg calcium plus 25 µg (1000 IU) vitamin D3. Subjects were 
randomly assigned into one of the two groups and consumed one serving of the orange 
juice per day for 12 weeks. Blood was taken each week during the study to measure 
serum 25(OH)D. The group that received the orange juice containing vitamin D3 had 
significantly higher serum 25(OH) D levels than at baseline as well as compared to the 
control group. 
In a fortification study using bread as the delivery medium, Natri et al. (2006) 
provided 10 µg (400 IU) of vitamin D3 from fortified wheat or rye breads daily for 3 
weeks to 41 healthy, middle-aged women. The change in 25(OH)D in the two fortified 
bread groups were compared with a group receiving unfortified wheat bread, and a 
group receiving unfortified wheat bread plus a 10 µg vitamin D supplement. The 
changes in 25(OH)D in the fortified wheat bread, fortified rye bread, unfortified bread, 
and bread plus supplement groups were 16.3 ± 6.6, 14.9 ± 6.2, -0.3 ± 4.0, and 19.5 ± 
10.1 nmol/L, respectively. The increase in the bread fortification groups was not 
significantly different from the group that received the same amount of vitamin D as a 
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supplement. The people with the lowest baseline vitamin D status seemed to respond the 
best to the vitamin D from the bread or supplement (Natri et al., 2006).  
In another vitamin D fortification study, J. L. Johnson et al. (2005) showed that 
vitamin D in fortified processed cheese is bioavailable. However, the study did not show 
an increase in serum 25(OH)D concentrations after the elderly subjects consumed the 
cheese for two months, which provided a daily dose of 15 µg. The investigators 
speculated that this could have been due to higher baseline concentrations in the group 
receiving the fortified cheese compared to the groups not receiving the product.  
 
2.2.3 Vitamin B12 
2.2.3.1 Metabolism 
Vitamin B12, or cobalamin, functions in two coenzyme forms: adenosylcobalamin 
and methylcobalamin. Adenosylcobalamin acts as a coenzyme for methylmalonyl-CoA 
mutase and leucine mutase which play a role in the metabolism of propionate and amino 
acids. Methylcobalamin acts as a coenzyme for methionine synthetase which functions 
in single carbon metabolism (Mahan & Escott-Stump, 2004). The role of vitamin B12 as 
a coenzyme is essential for normal functioning of all cells, and especially for cells of the 
gastrointestinal tract, bone marrow, and nervous tissue. Vitamin B12 is absorbed by 
active transport as well as about 1% by simple diffusion. Intrinsic factor, a binding 
protein found in gastric secretions, mediates the active transport of cobalamin. After 
absorption into the circulatory system and transportation by glycoproteins and 
transcobalamins I and II, vitamin B12 can be stored in the liver in amounts as much as 
2000 µg, which can provide about 5-7 years worth of the vitamin (Mahan & Escott-
Stump, 2004).  
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Vitamin B12 is found naturally in foods of animal origin as well as in some plant-
based foods that have been fortified. Meat, fish, poultry, and milk are generally the 
greatest contributors to adult intake in Canada and the United States. Cyanocobalamin is 
the primary form of vitamin B12 supplement available in Canada (Institute of Medicine, 
1998). The EAR and RDA for vitamin B12 for adults aged ≥51 years are 2.0 µg/day and 
2.4 µg/day, respectively. The Tolerable Upper Intake Level (UL) for this vitamin is 
unknown (Institute of Medicine, 1998). 
 
2.2.3.2 Biomarkers 
The primary criterion used to set the EAR for vitamin B12 was the maintenance of 
hematological status and serum vitamin B12 values (Institute of Medicine, 1998). Table 
2.4 summarizes the available markers for vitamin B12 status and the advantages and 
disadvantages of each.  
The Merck Manual states that the normal range for serum vitamin B12 is 200-800 
pg/mL (150-590 pmol/L) (Merck Research Laboratories, 2006) while others refer to the 
lower limit for normal serum cobalamin as 150 – 300 pmol/L (Dhonukshe-Rutten, van 
Zutphen, de Groot, Eussen, Blom, & van Staveren, 2005). It has been suggested that 
serum cut-off values for diagnosing vitamin B12 deficiency are too low and should be 
increased to 258 pmol/L (L. H. Allen & Casterline, 1994). Therefore, the normal 
reference range for serum vitamin B12 may be defined as 300-590 pmol/L, with < 150 
pmol/L indicating deficiency, and 150-300 pmol/L indicating inadequate levels. Low or 
low-normal levels of serum vitamin B12 likely reflect a deficiency, even if it is 
subclinical, because other markers of vitamin B12 status (serum methylmalonic acid and 
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homocysteine) have been shown to respond to treatment with vitamin B12 in elderly 
populations (R. H. Allen, Lindenbaum, & Stabler, 1995). 
 
Table 2.4 Vitamin B12 biomarkers and their advantages and disadvantages. 
 
Indicator Advantages Disadvantages 
 
Serum vitamin B12 - Commonly used in research 
studies 
- Used in setting the EAR1 
- No universally accepted cut-off 
value for defining cobalamin 
deficiency 
- Difficult to interpret in the 
elderly since many have low or 
low-normal levels without 
symptoms 
 
Serum 
methylmalonic 
acid (MMA) 
- Highly specific to vitamin 
B12 deficiency 
- Could not be used as criterion 
for setting EAR because of a 
lack of direct data1 
- Levels affected by renal function 
which declines with age2 
- Difficult and costly to measure3  
- May not predict clinical 
manifestations of deficiency4 
- Using as the only indicator of 
B12 status may not predict 
clinical manifestations of 
deficiency5 
 
Serum holo-
transcobalamin 
- Represents form available 
for use by tissue 
- Test not readily available6 
 
Serum total 
homocysteine 
- Can indicate subclinical 
deficiency 
- Levels also affected by folate 
and vitamin B6 status1 
 
1(Institute of Medicine, 1998) 
2(Loikas et al., 2007) 
3(L. H. Allen & Casterline, 1994) 
4(Nilsson, 2002) 
5(Hvas, Lous, Ellegaard, & Nexo, 2002) 
6(Kapadia, 2000) 
 
2.2.3.3 Prevalence, Causes and Consequences of Deficiency 
Studies suggest that metabolically significant vitamin B12 deficiency in the elderly 
is more common than previously thought (Clarke, 2001). The prevalence of deficiency is 
about 20% in the general population of industrialized countries and increases to 30-40% 
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in elderly people living in institutions or who are sick (Andres et al., 2004). Even in 
geriatric specialty clinics where clinicians routinely screen their patients for cobalamin 
deficiency, the prevalence has been found to be high (13%) (Rajan, Wallace, Beresford, 
Brodkin, Allen, & Stabler, 2002). However, the exact prevalence is difficult to 
determine because of the several different definitions and indicators of vitamin B12 
deficiency described above (Park & Johnson, 2006). Many people, with serum vitamin 
concentrations that are considered within the normal range, are metabolically deficient 
in cobalamin (Lindenbaum, Rosenberg, Wilson, Stabler, & Allen, 1994). Regardless of 
the definition used, it is evident that the prevalence of vitamin B12 deficiency increases 
with age (Clarke et al., 2004; Lindenbaum et al., 1994).  
Vitamin B12 is of particular concern for the elderly population because 10-30% of 
older people may be unable to absorb naturally occurring vitamin B12, most likely due to 
atrophic gastritis. More than 40% of patients over 80 years are estimated to suffer from 
this condition which inhibits the ability to release cobalamin bound to protein, resulting 
in decreased absorption (Andres et al., 2004). Food-cobalamin malabsorption may be 
associated with significant neurologic, psychologic, and hematologic abnormalities and 
is likely the main cause of vitamin B12 deficiency in the elderly (Andres et al., 2005). It 
is advisable that people over 50 years meet their vitamin B12 needs with the crystalline 
form of the vitamin, either by consuming foods fortified with vitamin B12 or by taking a 
supplement that contains it (Institue of Medicine, 1998). Crystalline vitamin B12 
absorption is normal in most people with atrophic gastritis because intrinsic factor is 
usually still present in adequate amounts (Russell, Baik, & Kehayias, 2001). Oral 
crystalline cyanocobalamin is effective at treating vitamin B12 deficiency resulting from 
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food-cobalamin malabsorption and serum levels can be returned to normal in 
approximately one month (Andres et al., 2003).  
Other factors that contribute to food-cobalamin malabsorption in the elderly 
include chronic Helicobacter pylori infection and intestinal microbial proliferation 
(which can be caused by antibiotic treatment), chronic alcoholism, gastric surgery, 
partial pancreatic exocrine failure, and Sjogren’s syndrome (Andres et al., 2004). The 
long-term use of certain medications can also lead to low vitamin B12 status. Prolonged 
use of H2-receptor antagonists and proton-pump inhibitors may impair the absorption of 
protein-bound vitamin B12 (Ruscin, Page, & Valuck, 2002). Metformin, a drug that is 
commonly used to treat people with type II diabetes, has been shown to decrease levels 
of folate and vitamin B12 (Wulffele, Kooy, Lehert, Bets, Ogterop, Borger van der Burg, 
2003). Pernicious anemia, an autoimmune disease characterized by the destruction of the 
gastric mucosa, is another cause of cobalamin deficiency and results in a lack of intrinsic 
factor so vitamin B12 is not absorbed (Andres et al., 2004). Vitamin B12 is secreted in the 
bile, but most of it is reabsorbed in healthy individuals. In people without intrinsic 
factor, vitamin B12 is excreted in the stool rather than reabsorbed which results in a 
deficiency that can develop quite quickly compared to someone who does not ingest the 
vitamin (Institute of Medicine, 1998).  
Vitamin B12 deficiency is often not recognized because the clinical signs are subtle 
(Andres et al., 2004). Hematological, neurological, and gastrointestinal effects can result 
from a deficiency in vitamin B12 (Institute of Medicine, 1998). The hematological 
effects include weakness, fatigue, shortness of breath, and palpitations. The anemia that 
results from a vitamin B12 deficiency produces oversized erythrocytes, or macrocytosis. 
There is also usually some degree of neutropenia and thrombocytopenia. These 
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hematological complications are completely resolved with vitamin B12 treatment. 
Neurological impairment due to vitamin B12 deficiency can be evident even in the 
absence of anemia (Lindenbaum et al., 1994) and is often the only clinical manifestation 
(Institute of Medicine, 1998). Neurological abnormalities are due to patchy 
demyelinization in the spinal cord, peripheral nerves, cerebral cortex, and cranial nerves 
(R. H. Allen et al., 1995). Symptoms of this nervous system damage include tingling and 
numbness in the extremities, gait disturbances, loss of concentration, memory loss, 
disorientation, dementia, mood changes, visual disturbances, insomnia, impotency, and 
incontinence of the bowel and bladder. Gastrointestinal effects of deficiency include 
sore tongue, loss of appetite, flatulence, and constipation (Institute of Medicine, 1998). 
Edema is another possible symptom of vitamin B12 deficiency (Henoun Loukili, Noel, 
Ben Abdelghani, Locatelli, Blickle, & Andres, 2005).  
2.2.3.4 Dosage and Analysis 
The intake of synthetic cobalamin appears to correspond to serum cobalamin 
levels and taking vitamin B12 supplements provides protection against low levels 
(Garcia, Paris-Pombo, Evans, Day, & Freedman, 2002). However, the exact dose needed 
to maintain adequate serum levels is unclear. Rajan, Wallace, Beresford, Brodkin, Allen, 
and Stabler (2002) found that only 4% of subjects with synthetic cobalamin intakes 
above 12 µg were deficient and that no subjects with intakes greater than 50 µg were 
deficient. Garcia et al. (2002) found a dose-effect relationship between oral cobalamin 
supplement intake and serum cobalamin, methylmalonic acid (MMA), homocysteine, 
and methylcitric acid levels. Bor, Lydeking-Olsen, Moller, and Nexo (2006) measured 
transcobalamin (TC), holo-TC, TC saturation, MMA, and total homocysteine levels and 
found that a daily dose of 6 µg of vitamin B12 will result in a steady concentration of 
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these indicators of vitamin B12 status and that vitamin B12 intake between 6 and 10 µg 
per day might help correct low vitamin B12 status. Oakley (2004) found that 6 µg/day of 
oral vitamin B12 is very effective in reducing the proportion of elderly people with low 
vitamin B12 status and that those who do not take supplements are 300% more likely to 
have a pre-clinical vitamin B12 deficiency. However, the researchers also stated that 
some people will need to consume more than 6 µg/day in order to prevent a pre-clinical 
vitamin B12 deficiency. Campbell, Miller, Green, Haan, and Allen (2003) found that 
subjects deficient in vitamin B12 consumed less of the vitamin from supplements and 
fortified beverages compared to subjects with marginal or normal vitamin B12 levels. 
A study by Seal, Metz, Flicker, and Melny (2002) was performed to “establish the 
minimum daily dose of vitamin B12 to restore to normal the low serum vitamin B12 
concentrations in older people”. The study lasted four weeks and compared two dose 
levels of vitamin B12, 10 and 50 µg/day, with placebo. The study concluded that 
supplementation with 50 µg/day of cyanocobalamin produced a significant increase in 
serum vitamin B12, whereas 10 µg/day was not significantly different than placebo. 
Blacher et al. (2007) found that a dose of 5.9 µg/day of vitamin B12 is needed to increase 
serum concentrations of the vitamin by 37 pmol/L in elderly subjects with low serum 
vitamin B12 status. In a review by Park and Johnson (2006) the authors concluded that 
doses of vitamin B12 ≤ 50 µg/day for short periods of time do not increase serum or 
plasma levels of vitamin B12 to levels above ~260 pmol/L and that more than 100 µg is 
needed for at least eight weeks to lower MMA to less than 300 nmol/L. Stabler, 
Lindenbaum, and Allen (1997) concluded that an adequate daily oral dose of vitamin B12 
would be greater than 6 µg but less than 300 µg. Wolters, Strohle, and Hahn (2004) 
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stated that general supplementation in the elderly with > 50 µg/day of vitamin B12 
should be considered. 
A daily intake of oral vitamin B12 at the amount recommended by the RDA is 
likely not adequate to recover from vitamin B12 deficiency and there does not appear to 
be risks involved with higher amounts of vitamin B12 intake (Food and Nutrition 
Program of the Pan American Health Organization, March of Dimes, Centers for 
Disease Control and Prevention, 2004). Toxicity is not apparent even at levels up to 
10,000 times the requirements, although the safe upper intake level is unknown 
(Dharmarajan & Norkus, 2001). Andres et al. (2003) found that an oral dosage of 250-
1000 µg/day for one month may be an effective treatment for vitamin B12 deficiencies 
that are not related to pernicious anemia. Eussen et al. (2005) stated that a dose more 
than 200 times greater than the RDA is needed to correct a mild vitamin B12 deficiency. 
Kuzminski, Del Giacco, Allen, Stabler, and Lindenbaum (1998) found that 2 mg/day of 
oral cyanocobalamin was as effective as a 1 mg intramuscular dosage administered 
monthly. A daily oral dose of 1000 µg vitamin B12 was found to maintain serum vitamin 
B12 levels in patients who were previously maintained on vitamin B12 injections 
(Nyholm et al., 2003).  
Older radioassays overestimated vitamin B12 status which led to individuals, who 
actually were deficient, to be classified as having sufficient levels. This occurred 
because the assays would measure non-functional analogs of the vitamin but this has 
been resolved with the use of purified intrinsic factor in commercial radioassay kits 
(Gibson, 2005). An even newer method to measure serum cobalamin levels is the non-
isotopic serum vitamin B12 assay which uses a higher cut-off value for deficiency. Cut-
off values for serum cobalamin are inconsistent in the literature and because cobalamin 
33 
levels depend on the type of analytical test used, the laboratory conducting the analysis, 
and the sample size, Gibson (2005) recommends that each laboratory set its own 
reference values.  
2.2.3.5 Fortification 
The level of vitamin B12 fortification needed to prevent cobalamin deficiency is 
uncertain. Seal et al. (2002) recommend that food fortification should aim to supply at 
least an additional 50 µg/day. Another study found that 1000 µg cobalamin per day for 
12 weeks delivered via fortified milk was as easily absorbed as the same amount 
delivered as crystalline cobalamin in capsule (Dhonukshe-Rutten et al., 2005). This 
study concluded that additional studies are needed to determine whether lower doses of 
the vitamin can be used in fortification to prevent cobalamin deficiency. A study that 
used vitamin B12 supplements at doses of either 10 µg or 50 µg per day for four weeks 
concluded that food fortification should provide an additional 50 µg of vitamin B12 
daily, because they did not find an improvement with an additional 10 µg/day (Seal et 
al., 2002). However, another study found that lower levels of fortification are capable of 
improving vitamin B12 status. A breakfast cereal fortified to provide 4.8 µg vitamin B12, 
440 µg folate, and 1.8 mg vitamin B6 per one cup serving significantly improved vitamin 
and homocysteine levels. The study included adults over 50 who consumed one serving 
of the cereal daily for three months (Tucker, Olson, Bakun, Dallal, Selhub, & 
Rosenburg, 2004). Oakley (2004) suggests that vitamin B12 fortification should be at a 
level of 10 µg per 100 g of grain which would result in a median vitamin B12 intake of 
approximately 15 µg/day. 
A concern with fortification that has the potential to affect food manufacturers is 
that the natural colour of crystalline vitamin B12 may turn grain products pink. However, 
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no difference in colour was found between vitamin B12 fortified and unfortified bread 
with 25, 100, or 500 µg of vitamin B12 per 100g of bread. Only at a high level of 
fortification (1000 µg/100 g bread) was a difference detected with the appearance of the 
bread being off-white with a trace of pink colour (Herbert & Bigaouette, 1997).  
 
2.2.4 Folate 
2.2.4.1 Metabolism 
Folate is a B-vitamin that functions as a co-enzyme in single-carbon transfer 
reactions and is essential for the metabolism of nucleic and amino acids (Institute of 
Medicine, 1998). Foods that are rich in folate include fortified grain products, dark green 
vegetables, and legumes. Folate refers to the naturally-occurring folate found in food 
while folic acid refers to the form used in vitamin supplements and fortified foods, 
although these terms are often used interchangeably. Folic acid is more easily absorbed 
by the body than folate. In order to compensate for this difference in bioavailability, a 
conversion unit is used which is termed dietary folate equivalents (DFE). Dietary folate 
equivalents are calculated as 1.0 µg of food folate equals 1.0 µg DFE. Folic acid from a 
fortified food or supplement is equal to 1 µg of folate in food multiplied by 2.0 if 
consumed on an empty stomach and multiplied by 1.7 if consumed with food (Otten et 
al., 2006). The EAR and RDA for adults ≥51 years is 320 and 400 µg per day, 
respectively, and the UL is 1000 µg/day for folic acid from fortified foods and 
supplements (Institute of Medicine, 1998). 
2.2.4.2 Biomarkers 
Serum, plasma, whole blood, and red blood cell (RBC) folate assays are available 
to determine folate status (Hultberg, Nilsson, Isaksson, & Gustafson, 2002). Inadequate 
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folate intake first leads to a decrease in serum folate concentration, then to a decrease in 
erythrocyte folate concentration. This will eventually lead to macrocytic anemia, 
characterized by a low erythrocyte count, as well as low hematocrit and hemoglobin 
(Institute of Medicine, 1998). The Dietary Reference Intakes used RBC and serum folate 
levels as well as plasma homocysteine as criteria for determining folate requirements for 
several of the life stage groups (Institute of Medicine, 1998). Serum folate is a sensitive 
indicator of dietary folate intake and serum folate has been shown to respond to an 
increase in dietary folate intake in as little as four weeks (Venn et al., 2002).  
K. A. Johnson et al. (2002) recommend using serum folate to determine folate status, 
unless there has been a recent change in diet in which case they recommend using RBC 
folate as it is more indicative of folate stores. A problem with using RBC folate in 
repletion studies is that because red blood cells have a life span of 120 days and only 
accumulate folate during their formation, a longer repletion period is needed to observe 
a change in RBC folate levels (Kauwell et al., 2000). A study using a daily 400 µg 
supplement measured erythrocyte folate and found an increase in folate concentrations 
after 12 weeks (Adank, Green, Skeaff, & Briars, 2003).  
According to the Merck Manual, the normal value for serum folate is >4.3 nmol/L 
(1.9 ng/mL) (Merck Research Laboratories, 2006). However, the cut-off value depends 
on the testing method and other sources quote different cut-off values for serum folate. 
Several authors report using a cut-off value of 6.8 nmol/L (Pfeiffer, Caudill, Gunter, 
Osterloh, & Sampson, 2005; Rampersaud, Kauwell, & Bailey, 2003; Ubbink, 1998). 
Other evidence suggests that the cut-off value should be higher. Hultberg et al. (2002) 
suggests that, based on studies using homocysteine to redefine the lower limit, the cut-
off value should be 10-15 nmol/L.  
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2.2.4.3 Prevalence and Causes of Deficiency 
Elderly people have been shown to have an increased risk for low folate status 
(Clarke et al., 2004; Lokk, 2003) and those who are institutionalized have been shown to 
have lower levels than people in the community (Matthews, 1995). The prevalence of 
folate malnutrition in the elderly has been estimated at 11 - 28% (Keane, O'Broin, 
Kelleher, Coakley, & Walsh, 1998). There are several possible causes for folate 
deficiency. Insufficient food intake, which is often seen in the elderly, is a common 
cause of poor folate status (Lokk, 2003). People consuming a pureed diet may also be at 
increased risk for folate deficiency because it may be more difficult to provide high 
folate foods, such as leafy green vegetables and folate-fortified grain products, in a 
pureed consistency (Adolphe et al., 2006).  
Folate absorption is optimized within a certain pH range and can be impaired in 
the elderly due to age-related achlorhydria (Lokk, 2003). Certain drugs that are 
commonly prescribed to elderly patients can affect folate status through their effects on 
absorption or metabolism. Methotrexate, a drug used to treat neoplastic disease, asthma, 
inflammatory bowel disease, psoriasis, and rheumatoid arthritis, acts as a folate 
antagonist. Phenytoin, an anticonvulsant drug, impairs folate metabolism, and 
sulfasalazine, which is used to treat inflammatory bowel disorders, can inhibit folate 
absorption and metabolism (Rampersaud et al., 2003).  
2.2.4.4 Dosage and Analysis 
To determine how much folate is required to restore normal folate levels in elderly 
women after a moderate folate depletion period, Kauwell et al. (2000) compared the 
effects of diets containing 200 or 415 µg/day of folate (provided as a mixture of folic 
acid and folate) on serum folate, RBC folate, and homocysteine concentration. The study 
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consisted of two phases. Phase I was a 49 day folate depletion phase during which time 
all subjects received a folate-restricted diet containing 118 ± 25 µg/d folate. Serum 
folate concentrations dropped from 45.7 ± 27.0 nmol/L at baseline to 13.7 ± 7.0 nmol/L 
after the depletion phase. Phase II was a 49 day repletion stage during which time 
subjects were divided into four groups, all of which continued to receive the folate-
restricted diet. In addition, the groups received a folic acid fortified apple juice 
supplement and/or orange juice which naturally contains folate in the following 
combinations: Group A 10 µg folic acid, 70 µg folate; Group B 137 µg folic acid, 155 
µg folate; Group C 82 µg folic acid, 0 µg folate; Group D 301 µg folic acid, 0 µg folate. 
The study found that the two groups that received 415 µg/d (groups B and D) had 
improved serum folate and homocysteine levels compared to the two groups that 
received 200 µg/d folate (groups A and C). Mean serum folate concentrations increased 
from 12.1 ± 7.2 nmol/L to 14.0 ± 7.6 nmol/L in the groups receiving 200 µg/d and from 
15.6 ± 6.5 to 31.4 ± 9.9 nmol/L in the groups receiving 415 µg/d. Red blood cell folate 
did not improve which was likely due to the short study period (49 days) and long life 
span of red blood cells (120 days) during which time folate is acquired. Another study 
examined the effect of breakfast cereals fortified with either 100, 200 or 300 µg folic 
acid on serum folate concentrations (Venn et al., 2002). At baseline, serum folate 
concentrations for the control, 100, 200 or 300 µg/d groups were 18, 18, 17 and 18 
nmol/L, respectively. Four weeks later, serum folate concentrations were 18, 23, 28 and 
33 nmol/L in the control, 100, 200 or 300 µg/d groups, respectively (Venn et al., 2002).  
Serum folate can be measured using a number of different techniques, including 
microbiological or competitive binding assays. The microbiological method is the best 
technique for assessing total serum folate because it responds to the greatest number of 
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folate derivatives (Gibson, 2005). The advantage of competitive binding assays is that 
they are rapid. A number of detective systems can be used with the competitive binding 
assays, including radioisotope dilution, enzyme-linked assays, and chemiluminescent 
tags (Gibson, 2005). Newer techniques to analyze folate include chemiluminescence, ion 
capture, HPLC with fluorescence detection, gas chromatography and liquid 
chromatography. Because of the variety of methods available, method-specific reference 
ranges need to be developed for which classification for deficiency is confirmed using 
other hematological symptoms (Gibson, 2005). 
2.2.4.5 Fortification 
In Canada, folic acid fortification of cereal grain products became mandatory in 
November 1998 at a level of 150 – 200 µg folic acid per 100 g of product (Public Health 
Agency of Canada, 2004). The United States Food and Drug Administration also 
mandated folic acid fortification at a level of 140 µg per 100 g of cereal grain product 
which was projected to increase the average folic acid intake by 100 µg/day 
(Choumenkovitch, Jacques, Nadeau, Wilson, Rosenburg, & Selhub, 2001). The 
introduction of mandatory folic acid fortification of grain products has been shown to 
improve folate nutritional status (Choumenkovitch et al., 2001; Ray, 2004). However, it 
is unlikely that the fortification has contributed to an increase in folic acid intake for 
elderly LTC residents consuming a pureed diet as there may be few grain products 
included on pureed menus due to the difficulty in producing pureed grain products 
(Adolphe et al., 2006). For example, bread, which is a staple food in regular-texture 
diets, is not appropriate for people on a pureed diet unless it is in a specially formulated 
pureed product. 
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Two previous studies have examined folic acid fortification of foods other than 
grain products. A cross-sectional study by Keane et al. (1998) examined the effect of 
milk fortified with folic acid on the folate status of an elderly institutionalized 
population. The subjects consisted of LTC residents from three facilities. One facility 
had been serving folic acid fortified milk (38 µg/100 ml) for at least six months prior to 
the study and  two facilities that served as the control served milk without additional 
folic acid (4 µg/100 ml). Serum and RBC folate levels were significantly higher in the 
group that had been receiving the folic acid fortified milk. Mean serum folate 
concentrations were 5.81 µg/L for the fortified group and 2.16 µg/L for the control 
group (P < 0.001; reference range 2.7 – 20 µg/L). Mean RBC folate concentrations were 
316.5 µg/L for the fortified group and 196.1 µg/L for the control group (P < 0.001; 
reference range 150 - 1000 µg/L). However, milk may not be the ideal medium in which 
to deliver folic acid as it may affect the bioavailability of folate. A study found that 
folate is better absorbed from fermented milk than from pasteurized milk due to the 
denaturation of folate-binding proteins in the fermented milk (Witthoft et al., 2006). 
 
2.2.5 Folate and Vitamin B12 Interaction 
2.2.5.1 Overview 
Folic acid and vitamin B12 interact metabolically. Both folic acid and vitamin B12 
deficiencies cause hematological abnormalities that are indistinguishable from each 
other. However, folic acid deficiency does not result in neurological disorders as does 
vitamin B12 deficiency (R. H. Allen et al., 1995). Supplementation with folic acid can 
correct the anemia associated with vitamin B12 deficiency but will not prevent or correct 
damage to the nervous system which is caused by vitamin B12 deficiency (Czernichow  
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et al., 2005). The masking of a vitamin B12 deficiency is particularly a concern in elderly 
populations since malabsorption and the prevalence of deficiency increase with age 
(Clarke, 2001; Koehler, Pareo-Tubbeh, Romero, Baumgartner, & Garry, 1997; Food and 
Nutrition Program of the Pan American Health Organization, March of Dimes, Centers 
for Disease Control and Prevention, 2004). To help avoid this problem, the UL for 
synthetic folic acid from fortification and supplementation was set at 1000 µg/day 
(Institute of Medicine, 1998).  
As a result of the possible masking of vitamin B12 deficiency by folic acid, 
concern has been raised that vitamin B12 fortification should occur alongside folic acid 
fortification of grain products. Although this idea has a considerable amount of support, 
the amount of vitamin B12 that should be added is uncertain (Ray, Vermeulen, Langman, 
Boss, & Cole, 2003; Food and Nutrition Program of the Pan American Health 
Organization, March of Dimes, Centers for Disease Control and Prevention, 2004). 
Herbert & Bigaouette (1997) suggest that 25 µg of vitamin B12 per 100g of product or 
folic acid supplement should be added. At this level an individual consuming 227 g  
(8 oz.) of grain products per day would ingest more than 56 µg of vitamin B12 (Lavine, 
1997), which is well above the recommendations put forth in the DRI report (Institute of 
Medicine, 1998). Such a high level of vitamin B12 fortification has been disputed when 
there is not sufficient evidence to support intakes this high for the general population 
(Lavine, 1997). Thus, vitamin B12 fortified foods developed specifically for populations 
at risk for deficiency, such as the elderly, may be more appropriate. 
Vitamin B12 and folate are essential components in the metabolism of 
homocysteine. Since mandatory folic acid fortification has been implemented in the U.S. 
there has been a modest decrease in homocysteine levels (J. L. Anderson, Jensen, 
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Carlquist, Bair, Horne, & Muhlestein, 2004). Homocysteine is a thiol-containing amino 
acid which, in the presence of catalysts, produces reactive oxygen species resulting in 
cell damage caused by oxidative stress (McPherson & Shepherd, 2006).  
2.2.5.2 Cardiovascular Disease 
Several decades ago, it was observed that individuals with homocysteinuria, a 
genetic disorder resulting in very high blood homocysteine concentrations, have 
premature vascular disease. This led to the theory that elevated homocysteine may be a 
risk factor for cardiovascular disease (McCully, 1969). Since this observation was made, 
there has been a vast amount of research into the relationship between homocysteine and 
cardiovascular disease.  
To combine the results of the many observational studies performed in this area, a 
meta-analysis of 30 prospective or retrospective studies was completed to assess the 
relationship of homocysteine concentrations with ischemic heart disease and stroke 
(Homocysteine Studies Collaboration, 2002). The meta-analysis found that a 25% lower 
homocysteine level was associated with an 11% lower ischemic heart disease risk and 
about a 19% lower risk of stroke. There are currently several large clinical trials 
underway to examine the relationship between folic acid and vitamin B12 
supplementation, homocysteine, and cardiovascular disease. A review by Clarke, 
Lewington, Sherliker, and Armitage (2007) summarized the results of four of these trials 
for which results are available. The trials were designed several years ago when the 
association of homocysteine with cardiovascular disease was believed to be stronger 
than what is currently thought. Because of this, even the combined results of these four 
trials had limited statistical power to detect a 10% difference in cardiovascular disease 
risk (Clarke et al., 2007). Therefore, more evidence is needed before recommendations 
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are made regarding folic acid and vitamin B12 supplementation to decrease homocysteine 
levels and the risk of cardiovascular disease. 
2.2.5.3 Cognitive Function 
Low levels of circulating folate and vitamin B12 or high levels of homocysteine 
may be associated with poor cognitive function in the elderly. Recent studies have 
examined the relationships between folate, vitamin B12, homocysteine, and cognitive 
function and have found mixed results. Haan et al. (2007) examined the association 
between homocysteine, RBC folate, plasma vitamin B12, and dementia and cognitive 
impairment in an elderly cohort of Mexican Americans. High homocysteine was 
associated with a greater risk of dementia or cognitive impairment suggesting that higher 
levels of plasma vitamin B12 may reduce the risk of dementia or cognitive impairment. 
In this study, RBC folate was not associated with dementia or cognitive impairment. A 
study by Feng, Ng, Chuah, Niti, and Kua (2006) examined the independent associations 
of homocysteine, folate, and vitamin B12 in high-functioning Chinese older adults. The 
results showed that homocysteine was associated with constructional ability and 
information processing speed, folate was associated with episodic memory and language 
ability, but vitamin B12 was not associated with any cognitive performance. McCracken, 
Hudson, Ellis, and McCaddon (2006) studied two markers of vitamin B12 status, serum 
MMA and holotranscobalamin, in relation to cognitive function and concluded that 
vitamin B12 deficiency in the elderly is associated with lower scores of language 
comprehension and expression. Homocysteine was not measured in this study. A three 
year randomised, double-blind trial, involving 818 subjects, examined the effect of  
800 µg/d of oral folic acid on cognitive performance (Durga et al., 2007). The subjects 
had elevated homocysteine levels and were vitamin B12 replete. A sensitive tool to 
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assess cognitive functioning was used in the study instead of the commonly used Mini-
Mental Examination. The results showed that folic acid supplementation provided a 
beneficial effect on global cognitive function, and specifically on memory and 
information processing (Durga et al., 2007). 
Two Cochrane reviews have also been performed to examine the relationship 
between homocysteine, folic acid, vitamin B12, and cognition. One of the reviews 
analyzed the association between vitamin B12 and cognitive impairment and concluded 
that, at the time of the review, there was insufficient evidence to suggest that vitamin B12 
supplementation improves cognitive function (R. Malouf & Areosa Sastre, 2003). The 
other review examined the effect of folic acid, with or without vitamin B12, on cognition 
and dementia. Again, the authors concluded that at the time of the review there was 
insufficient evidence to suggest that folic acid, with or without vitamin B12, has a 
positive effect on cognitive function (M. Malouf, Grimley, & Areosa, 2003). Miller 
(2006) suggests that one possible reason for the inconsistent findings relating vitamin 
B12 to cognitive function is that more than one indicator needs to be measured in order to 
properly determine vitamin B12 status.  
 
2.3 FORTIFICATION 
2.3.1 Overview 
Over the past century, food fortification has been used to combat several 
debilitating conditions: iodine has been added to table salt to prevent goiter; vitamin D 
has been added to milk to prevent rickets; and most recently, mandatory fortification of 
grain products with folic acid has been implemented to decrease the incidence of neural 
tube defects. These are all large-scale, public health strategies to combat specific 
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disorders. Fortification has also been used for people with specific dietary needs. For 
example, weight loss products are fortified with vitamins and minerals to ensure that 
people on low calorie diets still receive adequate amounts of micronutrients. Food 
fortification may also have the potential to improve the nutritional and health status of 
other subgroups in the population that are known to be at high nutritional risk, such as 
the elderly. 
Although not yet studied, fortification of foods served at LTC facilities may be the 
most suitable way to improve the micronutrient intake of LTC residents, particularly for 
those requiring diet modification for dysphagia. As previously discussed, people 
consuming pureed diets have low energy intakes and thus are at risk of not receiving 
adequate amounts of nutrients. Fortification allows the provision of nutrient-dense foods 
to meet nutrient requirements without having to increase the volume of food consumed. 
Currently, planning a menu that offers the appropriate levels of nutrients results in the 
provision of large volumes of food and energy levels that are simply not feasible for this 
population, resulting in significant food wastage (Buchman, 1996). Providing foods that 
are fortified, yet indistinguishable from their unfortified counterparts, would ensure that 
acceptability of the overall diet will be optimized.  
There have been a limited number of studies that have examined foods for the 
elderly that are fortified with multiple vitamins and/or minerals. The goal of a study by 
de Jong, Chin, de Graaf et al. (2001) was to study the acceptance of micronutrient-dense 
foods compared to regular foods among the frail elderly. The study included two 
enriched products which, if consumed twice per day, delivered ~100% of the Dutch 
RDA of several vitamins and ~25-100% of the RDA of several minerals. The results of 
this study demonstrated that the development of fortified products is feasible, but that it 
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is extremely important to develop fortified foods that taste identical to their unfortified 
counterparts. Another study by this group (de Jong, Chin, de Groot et al., 2001) looked 
at the impact of fortified foods and exercise on blood vitamins and their biomarkers, and 
neuropsychological functioning in the frail elderly. After the 17 week trial, the results 
showed a beneficial effect of the fortified foods on the blood vitamin, homocysteine, and 
methylmalonic acid concentrations in Dutch frail elderly. Overall, fortified foods are an 
acceptable alternative if they are formulated to taste the same as regular foods, and they 
appear to be capable of improving blood vitamin levels of the elderly.  
 
2.3.2 Health Canada Guidelines 
Health Canada has recently completed a review of its food fortification policy 
(Health Canada, 2005). The policy provides an opportunity for the development of 
commercially-prepared fortified foods under the classification of “special purpose 
foods”. The policy defines special purpose foods as “foods that have been designed to 
perform a specific function, such as to replace a meal which necessitates a content of 
essential nutrients which cannot be achieved except by the addition of one or more of 
these nutrients. These foods include but are not limited to foods for special dietary use” 
(Health Canada, 2005, p. 18).  
As outlined in the policy (Health Canada, 2005), in order to have fortified special 
purpose foods approved for use, rationale for fortifying a special purpose food for a 
specific group is necessary. Such rationale includes: 
i. Evidence that the nutrition needs for the target group(s) are different from the 
general population, how and to what extent; this may require demonstration of 
inadequate intake or evidence of increased requirements. Intake data and /or 
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requirement data for the target group would provide the necessary evidence for 
nutrition needs. 
ii. Evidence supporting that the proposed levels of fortification contribute to meeting 
the identified needs. Modeling data to show how the product, when used as 
intended, contributes to intakes in the context of the total diet would be appropriate 
evidence. 
iii. Evidence that the proposed levels of fortification are safe and do not exceed the 
UL in the context of the total diet for the target group. This condition is an 
extension of the item ii) above in which upper levels of the intake distribution 
would be identified. 
     (Health Canada, 2005, p. 23-24). 
 
2.3.3 Determination of Fortification Levels 
The Dietary Reference Intakes provide valuable guidelines in assessing and 
planning dietary intakes of groups. For each nutrient, a set of reference values are 
determined. These are referred to as the Estimated Average Requirement (EAR), 
Recommended Dietary Allowance (RDA), Adequate Intake (AI), and Tolerable Upper 
Intake Level (UL). These values are defined as follows: 
• EAR: the average daily nutrient intake level that is estimated to meet the 
requirements of half of the healthy individuals in a particular life stage and gender 
group. 
• RDA: the average daily dietary nutrient intake level that is sufficient to meet the 
nutrient requirements of nearly all (97 – 98 percent) healthy individuals in a 
specific life stage and gender group. 
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• AI: the recommended average daily intake level based on observed or 
experimentally determined approximations or estimates of nutrient intake by a 
group (or groups) of apparently healthy people that are assumed to be adequate; 
used when an RDA cannot be determined. 
• UL: the highest average daily nutrient intake level that is likely to pose no risk of 
adverse health effects to almost all individuals in the general population. As intake 
increases above the UL, the potential risk of adverse effects may increase. 
     (Otten et al., 2006, p. 8) 
A limitation to using the DRIs as reference values for planning nutrient intakes of 
elderly people living in LTC is that the values were developed for a healthy population. 
However, the DRIs provide the only evidence-based recommendations that can be used 
for dietary assessment and planning. Planning nutrient intakes for a group is challenging 
because the amount and selection of foods can vary greatly between individuals in the 
group, even when the same meal is offered in an institutional setting. Long-term care 
residents are a very heterogenous population with considerable variation in their age, 
health status, nutritional status, physical activity level, and dependency on others to 
carry out their activities of daily living (Akner & Floistrup, 2003). The energy and 
nutrient intakes of LTC residents can vary by as much as eight-fold when intakes are 
expressed based on the amount ingested per kilogram of body weight (Akner & 
Floistrup, 2003).  
For nutrients that have an EAR and RDA, the EAR is used in conjunction with the 
usual intake distribution to develop a diet plan that provides an acceptably low 
prevalence of inadequate intakes within the group. The planning goal is to minimize the 
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prevalence of intakes below the EAR (Institute of Medicine, 2003). Using the EAR plus 
two standard deviations of group intake in the calculation of the target intake gives a 
value that would meet the needs of 97.5% of the group’s requirements. In other words, 
only 2.5% of the group would be at risk for inadequacy. For nutrients with an AI, the 
goal is to increase the group’s mean or median intake to the level of the AI. The UL, 
when available, can be used to plan a diet that provides a low prevalence of excessive 
intakes (Institute of Medicine, 2003).  
Another approach for determining fortification levels is suggested in Health 
Canada’s proposed policy for the addition of vitamins and minerals to food. The report 
suggests that special purpose foods being used as a meal replacement or nutritional 
supplement should be “formulated based on a defined nutrient contribution to the total 
daily intake, for example to provide 25% of the recommended daily intake in a serving 
of the food” (Health Canada, 2005, p. 19). Therefore, serving four fortified foods per 
day at 25% of the recommended daily intake in each serving will provide 100% of the 
RDA/AI per day from the fortified foods, assuming that the servings are completely 
consumed. 
 
2.3.4 Sensory Testing 
 Sensory evaluation of foods may be defined as the “science that uses human 
panelists and their senses of sight, smell, taste, touch and hearing to measure the sensory 
characteristics and acceptability of food products” (Watts, Ylimaki, Jeffery, & Elias, 
1989, p. 5). Sensory testing of fortified foods is important because it is critical to 
develop fortified foods that taste identical to their unfortified counterpart (de Jong, Chin, 
de Graaf et al., 2001). There are several types of sensory tests. Preference tests ask 
49 
panelists to express if one sample is preferred over another or if there is no preference. 
Acceptance tests are used to determine the degree of acceptance of a product. Hedonic 
tests measure the degree of liking for a product. Intensity ranking or scoring tests ask 
panelists to rank samples, or score them on line scales or category scales, based on the 
perceived intensity of a particular sensory characteristic. Discriminative tests are used to 
see if there is a difference between two samples (Watts et al., 1989). Thus, when testing 
to determine if there is a difference between fortified and unfortified foods, a 
discriminative test is necessary.  
 There are several different discriminative tests available. In the paired-
comparison test, panelists are given two samples and asked to identify which sample has 
the greater intensity of a specific characteristic, for example, which product is sweeter 
(Watts et al., 1989). Another discriminative test is the duo-trio test. In this test, panelists 
are given three samples, one of which is labeled R for reference and two other samples 
labeled with a 3-digit random code. One of the coded samples is the same as the 
reference and the other is different. The panelists are asked to choose which sample is 
the same (or different) than the reference (Watts et al., 1989).  
 A third type of discriminative test is the triangle test. The primary advantage of 
the triangle test is that it is a simple test that determines whether there are detectable 
differences between samples (Watts et al., 1989). Therefore, the triangle test was a 
suitable choice for the present study in order to determine if there was a taste difference 
between the fortified and unfortified pureed foods. The triangle test does not determine 
the size or direction of the difference but this information was not necessary in this 
study.  
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 To perform the triangle test, each panelist is given three coded samples and is 
told that two of the samples are the same and one is different. They are then asked to 
identify the odd sample (Poste, Mackie, Butler, & Larmond, 1991). It is common to use 
each sample as the duplicate for half of the tests and as the different sample for the other 
half (Poste et al., 1991). For example, when testing to see if there is a detectable taste 
difference between an unfortified food and the same food that has been fortified with 
vitamins, half of the panelists would receive two fortified samples and one unfortified 
sample, while the other half would receive two unfortified samples and one fortified 
sample.  
 To analyze the results of the triangle test, the number of correct identifications of 
the odd sample is compared to what you would expect by chance alone if there was no 
difference (i.e. one third of the time). Whether or not the number of the correct 
identifications is statistically significant can then be determined using statistical charts 
(Poste et al., 1991).  
 
2.4 DIETARY ASSESSMENT 
2.4.1 Methods of Dietary Assessment 
There are several types of dietary assessment techniques available for use in 
research. Since no one method of dietary assessment is suitable in all situations, the 
researcher must decide which technique is most appropriate for the study being 
performed. This decision depends on factors such as the number of subjects, subject 
characteristics, and the method of data analysis. When choosing which assessment 
method to use it is important to be aware of the advantages and disadvantages of each 
method. 
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In a 24 hour recall, subjects and/or their parents or caregivers are asked by a 
nutritionist who has been trained in interviewing techniques to recall the subject’s exact 
food intake during the previous 24 hour period or preceding day. Recalls may be done 
once or repeated several times per individual (Gibson, 2005). One of the advantages of 
using the 24 hour method is that the questions are open-ended so the researcher can get 
as much or as little detail as needed (Willett, 1998). Since the recalls do not require the 
subject to be literate they can be used with young children or people with limited reading 
ability. The major limitation to using the 24 hour recall method is that it relies on the 
individual’s short-term memory in order to be accurate. Therefore, this technique may 
not be suitable for certain populations such as the elderly (Willett, 1998). 
A food frequency questionnaire aims to assess the frequency with which food 
items or food groups are consumed during a specified time period. Questionnaires may 
be quantitative, semi-quantitative or qualitative (Gibson, 2005). Qualitative 
questionnaires do not include serving sizes, semi-quantitative questionnaires include one 
serving size for each food, and quantitative questionnaires allow the serving size and the 
frequency of intake to be determined by the subject. Food frequency questionnaires are 
often used when assessing large groups, such as in epidemiological studies, because they 
are relatively easy to administer and computerized scanning makes coding much faster 
(Gibson, 2005). Food frequency questionnaires are also useful for assessing long-term 
dietary intake (Willett, 1998). A disadvantage of food frequency questionnaires is that 
they are not based on actual intake and are, therefore, most useful to assess relative, not 
absolute, food intake.  
A diet history attempts to estimate the usual food intake and meal pattern of 
individuals over a relatively long period of time, often one month (Gibson, 2005). An 
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advantage of using a diet history is that information is obtained in a single interview 
instead of placing burden on subjects to record intake for several days (Sjoberg & 
Hulthen, 2004). However, there is no standardized protocol for taking a diet history, 
therefore the reliability and validity depends largely upon the techniques used by the 
person performing the interview. The interviewer must be highly trained in order to 
carry out the interviews in such a way that the questions asked do not bias the subject 
(R. D. Lee & Nieman, 2003).  
In the duplicate portions technique, participants are asked to collect a duplicate 
portion of all foods and beverages consumed over a 24 hour period in a container 
provided by the investigator, often for several consecutive 24 hour periods. The 
duplicate diet composites are then homogenized and later chemically analyzed. In 
addition, the participants are asked to make a written food record of daily food intakes to 
ascertain the foods and quantities consumed (Gibson, 2005). This technique is useful 
when studying groups that are suspected to be at risk of ingesting high levels of dietary 
contaminants (Gibson, 2005). It is also useful when studying dietary components that 
are not found in nutrient databases. Two other advantages of this technique are that it 
does not involve an interviewer and does not rely on memory. However, there are two 
major limitations to using the duplicate portion technique. Firstly, participants may alter 
their usual food consumption patterns during the study to make collecting the food easier 
(Gibson, 2005). Secondly, this method creates a large subject burden so subjects must be 
highly motivated. 
Food balance sheets provide a comprehensive picture of the pattern of a country’s 
food supply during a specified reference period, calculated from the annual production 
of food, changes in stock, imports and exports, and distribution of food over various uses 
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within the country (Gibson, 2005). This technique may be used to make inter-country 
comparisons of food supplies and associations between nutrition and mortality at 
national levels. However, these associations should be made with caution because other 
lifestyle factors may be equally as important (Gibson, 2005).  
Estimated food records are performed by having the subject use household 
measurements to estimate all foods and beverages consumed (Gibson, 2005). The 
advantages and disadvantages of estimated food records are similar to those of weighed 
food records, which are described in the following section. However, weighed food 
records are considered to be more accurate than an estimated food record (R. D. Lee & 
Nieman, 2003).  
 
2.4.2 Weighed Food Records 
Weighed food records are performed by having a research assistant weigh all 
foods and beverages prior to the subject consuming them (Gibson, 2005). Any leftovers 
are weighed by the research assistant after the subject is finished eating and the 
difference is calculated to determine the amount of food consumed. Having a research 
assistant perform the weighed food records helps to ensure that the measurements are 
done objectively and do not impact the accuracy of the intake measurements (Akner & 
Floistrup, 2003). 
There are several advantages of using weighed food records in research studies. 
Weighed food records are useful when comparing nutrition intakes with specific dietary 
recommendations and because they are based on actual intake, they may be used to 
estimate absolute energy and nutrient intakes (Willett, 1998). Records are open-ended 
and therefore can provide as little or as much detail necessary to answer the research 
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questions and can accommodate cultural diversity within the study population (Willett, 
1998). Weighed food records do not rely on memory and thus are a useful technique in 
elderly populations (Willett, 1998). Flexibility in analysis is another advantage of 
weighed food intakes. Data can be analyzed by nutrients, individual foods, any food 
grouping scheme, or by meals (Willett, 1998). Finally, a weighed food record is the most 
precise method available for estimating usual food and nutrient intakes of individuals 
and is often referred to as the “gold standard” against which other assessment methods 
are compared (Gibson, 2005).  
However, there are also limitations to using weighed food records. A single day of 
intake is unlikely to be representative of usual intake. Recording multiple days of intake 
can be burdensome for the researcher and the subjects (Willett, 1998). The research 
assistant, equipped with a scale, must always be available whenever the subject is eating 
(Gibson, 2005).  
In spite of these limitations, weighed food records performed by a research 
assistant are the most appropriate method of dietary assessment in an elderly LTC 
population. This method is accurate and does not require the subjects to perform any of 
the record keeping which would not be possible in an elderly population with a high 
prevalence of cognitive impairment.  
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CHAPTER 3 
RESEARCH METHODS
3.1 STUDY DESIGN 
There were two phases to the study. Phase I involved determining appropriate 
fortification levels for pureed foods, which included performing sensory testing of the 
pureed fortified foods to determine if there was a detectable difference in taste. Phase II 
involved feeding the fortified foods to long-term care residents to determine if the foods 
were capable of improving the nutritional status of the residents consuming them.  
 
3.2 PHASE I - DETERMINATION OF FORTIFICATION LEVELS 
3.2.1 Description of Pureed Foods 
The pureed menu at Parkridge Centre, where the subsequent trial of the fortified 
foods was planned to take place, followed a set meal pattern with a pureed meat, pureed 
vegetable, and mashed potatoes served at both lunch and supper. It was decided that 
pureed meat products and starch products (either mashed potato or a commercial pureed 
bread product) would be fortified since these foods were always offered at lunch and 
supper at Parkridge Centre, resulting in a total of four fortified pureed foods offered per 
day. Calcium-fortified juices had become common in the marketplace and thus it was 
decided that calcium and magnesium would be added to the juices instead of to the 
starch and meat. 
 
56 
3.2.2 Methods to Determine Fortification Levels 
There is no universally accepted method to determine fortification levels. 
Therefore, a combination of two methods was used in order to arrive at an appropriate 
level of fortification that would minimize inadequacies while preventing nutrient intakes 
above the UL. The first method used to calculate fortification levels was proposed by the 
Dietary Reference Intakes report on planning (Institute of Medicine, 2003). The report 
suggests using the formula “Estimated Average Requirement (EAR) plus 2 standard 
deviations (SD) of intake” for menu planning. This formula is used in menu planning 
with the goal of limiting the number of individuals within the group who are at risk for 
nutrient intake inadequacies. The value calculated by using this formula will herein be 
referred to as the “target intake”. However, to use the formula, the SD of intake [SDin] 
must be known. Fortunately we had this information from a previous study performed 
by our research group (Adolphe et al., 2006). The study included weighed food intakes 
for eight LTC residents consuming a pureed diet. Intakes were completed for the 
participants for a total of 6 days, 3 days prior to and 3 days after the intervention. 
Nutrient intake results from this study are shown in Appendix A. The mean nutrient 
intakes from the combined pre- and post-intervention weighed food records from the 
study were calculated since intake levels did not significantly change after the 
intervention. This provided a mean intake based on 6 days of food records for 8 subjects. 
Using these data, the target intake was then calculated for nutrients that have an EAR. 
This formula cannot be employed for nutrients without an established EAR. For these 
nutrients, the goal is to increase the group’s mean or median intake to the level of the AI 
(Institute of Medicine, 2003).  
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A potential problem with using this calculation for our population was that the 
nutrient distribution was fairly large for some nutrients. This created a risk that some 
intakes would exceed the UL. Therefore, Health Canada’s recommended method for 
determining fortification levels was used for comparison. The method suggests that 
special purpose foods being used as meal replacements or nutritional supplements 
should be “formulated based on a defined nutrient contribution to the total daily intake, 
for example to provide 25% of the recommended daily intake in a serving of the food” 
(Health Canada, 2005, p. 19). Since it was planned that the starch (bread product or 
mashed potatoes) and meat that were served at lunch and supper would be fortified, each 
resident would receive two fortified starch and two fortified meats per day. Therefore, 
25% of the recommended daily intake per serving would provide 100% of the RDA/AI 
per day from the fortified foods, assuming that the servings are completely consumed. 
Using a value of 25% of the recommended daily intake as per the Health Canada 
method and the EAR + 2SD formula for menu planning, the food intakes from our 
previous pureed food study were used to determine if various levels of fortification 
would increase nutrient intakes while not exceeding the UL. Using the food records 
from our previous study, the food record that had the lowest intake and the food record 
that had the highest intake for each nutrient were chosen. The fortified foods were then 
hypothetically substituted for the same food that was unfortified in the intake study to 
determine the nutrient intake level that would be achieved with fortification. A 
calculation was also performed using an “ideal” day of intake, i.e., if someone ate 
exactly what was provided to them on the menu. Again, fortified food substitutions were 
made, with both single and double portions of the fortified foods replacing the non-
fortified equivalents. Therefore, even if someone were to consume double portions of 
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the four fortified foods provided per day, it could be determined if the fortification level 
would result in an intake exceeding the UL.  
Fortification levels were not determined for vitamin A, vitamin K, and potassium 
because of the possible adverse effects. High intakes of vitamin A may increase the risk 
for low bone mineral content, fracture risk, and osteoporosis and intakes among the 
elderly in North America are generally adequate (Basu, 2006). Vitamin K and potassium 
have the potential to interact with medications prescribed for cardiovascular disease 
which are used by many elderly patients (Rohde, de Assis, & Rabelo, 2007; Sica, 2006).  
 
3.2.3 Sensory Testing of Fortified Foods 
 After the desired fortification levels were determined, triangle sensory tests were 
performed to determine if the addition of fortification powder to pureed foods resulted in 
a detectable difference in taste. The triangle tests were coordinated by a summer 
research assistant, Shannon Leydon. Sensory panelists were recruited by word-of-mouth 
and included University of Saskatchewan staff and students with no known allergies. 
Ethical approval (Apprendix C) was obtained from the University of Saskatchewan 
Biomedical Research Ethics Board (Bio-REB) and consent (Appendix D) was received 
from each participant. Each panelist received a $5 bookstore gift certificate and an ice-
cream treat as compensation for participation.  
 For each food item tested, each panelist received two sets of three samples that 
were coded with random three-digit numeric codes. One set contained two unfortified 
(control) samples and one fortified sample of the food item, and the other set contained 
one control sample and two fortified samples. The presentation order of the samples was 
rotated for each panelist. For each set, the panelists were instructed to taste each sample 
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using a different plastic spoon and rinse their mouth with water between each sample. 
The panelists were then asked to identify the odd sample by writing the code of the odd 
sample on the questionnaire form and to briefly describe why they felt the sample tasted 
differently. All sensory testing was performed in a controlled sensory evaluation 
laboratory with panelists sitting in individual booths. Statistical charts were used to 
determine the probability of the number of correct identifications of the odd sample 
(Poste et al., 1991). A P-value of > 0.05 indicated that there was not a detectable taste 
difference between the unfortified and fortified samples. 
 Six pureed foods were tested using three different fortification formulations. The 
first formulation tested contained vitamins and minerals (Table 3.1). The second 
formulation was exactly the same as that shown in Table 3.1, but iron was excluded. 
Lastly, a formulation was tested that contained only vitamins (Table 3.2). 
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 Table 3.1 Daminade 1119 vitamin and mineral formulation (Nealanders  
 International Inc.). 
 
Vitamins and Minerals Amount per 100 mg 
Vitamin D3 160 IU (4 µg) 
Vitamin E 5.97 IU (4 mg) 
Vitamin C (as Ascorbic Acid) 45 mg 
Vitamin B1 (as Thiamine Mononitrate) 0.4 mg 
Vitamin B2 (as Riboflavin) 0.5 mg 
Vitamin B3 (Niacinamide) 1 mg 
Vitamin B6 (as Pyridoxine HCl) 0.6 mg 
Vitamin B12  1 µg 
Folate (as Folic Acid) 100 µg 
Pantothenate (as Calcium Pantothenate) 1.25 mg 
Biotin 7.5 µg 
Iron (as Ferrous sulphate) 2 mg 
Copper (as Copper gluconate) 0.3 mg 
Zinc (as Zinc gluconate) 3 mg  
Manganese (Manganese sulphate) 0.5 mg 
Selenium (as Sodium selenite) 15 µg 
Molybdenum (as Sodium molybdate) 11 µg 
Chromium (as Chromium chloride) 7.5 µg 
Maltodextrin q.s. mg 
 
 Table 3.2 Daminade 1119 vitamin formulation (Nealanders International  
 Inc.). 
 
Vitamins Amount per 100 mg 
Vitamin D3 160 IU (4 µg) 
Vitamin E (dl-alpha tocopherol acetate) 5.97 IU (4 mg) 
Vitamin C (as Ascorbic Acid) 45 mg 
Vitamin B1 (as Thiamine Mononitrate) 0.4 mg 
Vitamin B2 (as Riboflavin) 0.5 mg 
Vitamin B3 (Niacinamide) 1 mg 
Vitamin B6 (as Pyridoxine HCl) 0.6 mg 
Vitamin B12  1 µg 
Folate (as Folic Acid) 100 µg 
Pantothenate (as Calcium Pantothenate) 1.25 mg 
Biotin 7.5 mcg 
Maltodextrin q.s. mg 
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3.3 PHASE II - FORTIFICATION TRIAL OF PUREED FOODS 
3.3.1 Recruitment 
Twelve subjects were recruited from three wards at Parkridge Centre, Saskatoon, 
Saskatchewan, Canada. The wards were chosen because they had the highest 
concentration of residents consuming a pureed diet. The number of wards was limited to 
three because of the logistical difficulties in performing weighed food intakes on 
multiple wards. Potential participants were identified by chart review. Subjects who 
were ≥ 50 years old and consumed a pureed diet daily were considered eligible to 
participate. Residents were excluded if they were deemed palliative, as determined by a 
note on the resident’s chart or reported by the nursing staff. Consent was provided by the 
residents or their family members (Appendix D). If the resident was not competent to 
consent to participate in the study, the resident’s next of kin was contacted by phone or 
mail. Ethical approval was obtained from the University of Saskatchewan, Biomedical 
Research Ethics Board (Appendix C). Operational approval was received from the 
Saskatoon Health Region, Strategic Health Information and Planning Services. Each 
participant, or the family member who consented on their behalf, received a $50 
Hudson’s Bay Company gift certificate as compensation for participation. 
 
3.3.2 Pureed Food Fortification 
Based on the results of the sensory testing, it was decided to proceed with 
fortification using only vitamins in order to minimize the flavour changes caused by the 
addition of the vitamin and mineral fortification powder to the pureed foods. Originally 
it was planned that the meat and starch (mashed potato or commercial pureed bread 
product) served at lunch and supper would be fortified. However, for logistical reasons, 
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it was decided instead to use only the pureed products already served at Parkridge 
Centre. Since they did not use a commercial bread product, it was decided that the 
pureed meat and vegetables served at lunch and supper would be fortified. To ensure 
that this change would not increase the fortification levels so that some residents would 
be at risk of exceeding the UL, the same methods were used as described in section 3.2.2 
but instead of substituting the starch foods, the hypothetical fortified vegetables were 
substituted for the unfortified vegetables in the intake data from our previous study with 
this population. Since the focus of the study became only vitamin fortification, the 
beverages that were originally planned to be fortified with calcium and magnesium were 
not used in this study.  
During the eight weeks of the fortification trial, a research assistant (Alanna Gibb) 
or graduate student (Jennifer Adolphe) visited Parkridge Centre every morning to add 
the fortification powder to the vegetables and meats that were served that day for lunch 
and supper. The vegetables were received from the supplier frozen. Approximately 8 kg 
of vegetables were used at both lunch and supper. The vegetables were cooked in a 
perforated pan in a commercial steamer until soft, and then placed into a food processor 
to be pureed. The fortification powder (100 mg powder/100 g vegetables) was sprinkled 
onto the vegetables prior to mixing in the food processor to achieve even distribution of 
the powder throughout the vegetables.  
The meat was purchased from the supplier as a frozen pureed product that was 
previously cooked. Approximately 7 kg of pureed meat was used at both lunch and 
supper. The meat was pulled from the freezer 2-3 days prior to reheating and placed in 
metal insert pans. Reheating was done approximately two hours prior to serving in a 
covered metal insert pan in a commercial steamer. The pans were then placed in 
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warming carts to keep hot until serving. For the meats served at lunch, the pans were 
removed from the warming carts, the fortification powder was sprinkled on top of the 
meat (100 mg powder/100 g meat), and then the powder was mixed into the meat using a 
hand-held stick blender. For the meat served at supper, the fortification powder was 
added to the meat prior to reheating in the steamer. To do this, the thawing meat was 
removed from the refrigerator and placed in a commercial food processor bowl. The 
fortification powder was then added to the bowl and the meat was thoroughly mixed in 
the food processor. The meat was then re-portioned into the metal insert pans and placed 
in the refrigerator until it was reheated for supper. All meat products were fortified 
except for fish, which was served three times during the three week menu cycle. Fish 
was excluded from fortification because the additional blending of the product to add the 
fortification powder resulted in a consistency that was too thin. 
The fortified pureed food was provided to all residents prescribed a pureed diet at 
Parkridge Centre, but food intakes and blood samples were only obtained from the study 
participants who provided consent. The fortified pureed foods were included in the menu 
for eight weeks, from the middle of April to the beginning of June, 2007. Initially the 
study was planned to begin in early February to prevent endogenous vitamin D synthesis 
if any of the participants were exposed to sunlight. Unfortunately, a flu outbreak at 
Parkridge Centre prevented the study from starting until later in the spring. However, 
since most of the study participants were immobile, the risk of vitamin D synthesis from 
sun exposure was minimal. 
A chart review was performed for all participants to gather information regarding 
their age, body weight, height, primary diagnosis, supplement usage, medications, and 
length of stay. Eleven of the twelve subjects recruited completed the study; one 
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participant passed away prior to the study end. Three day weighed food intakes were 
performed for 10 participants. One participant was excluded because she lived on a 
different unit in the facility and it was too labour-intensive to perform weighed intakes 
for only one person. To detect if the fortified foods had an effect on nutritional status, 
blood samples were drawn from 11 participants at baseline and 8 weeks after the 
introduction of the fortified pureed foods to measure serum cobalamin, folate, and 
25(OH)D levels. A sample of the fortification powder was analyzed using HPLC-UV to 
determine the actual content of vitamin D, vitamin B12, and folate. The analysis was 
contracted through SunWest Food Laboratory Ltd., Saskatoon, Saskatchewan. 
 
3.3.3 Analysis of Serum for Vitamin B12, Vitamin D and Folate 
 Blood samples were taken from the participants by the Gamma-Dynacare 
Medical Laboratories mobile phlebotomy service to measure serum levels of vitamin 
B12, vitamin D, and folate. The blood was collected by venipuncture using BD SST 
(Becton, Dickinson and Company Serum Separator Tube) vacutainers and BD Eclipse 
needles. The samples used to measure serum vitamin B12 were kept protected from light 
and analyzed the same day they were collected at St. Paul’s Hospital, Department of 
Laboratory Medicine, Saskatoon, Saskatchewan using an ARCHITECT B12 assay, a 
chemiluminescent microparticle intrinsic factor assay. Serum folate and 25(OH)D 
analysis was not available in Saskatoon so the samples were protected from light, frozen 
at -24°C and shipped on dry ice for analysis. Serum folate was analyzed at St. Michael’s 
Hospital, Toronto, Ontario using the Roche E170 electrochemiluminescence 
immunoassay. Serum 25(OH)D was measured using Liquid Chromatography – Mass 
Spectrometry at a provincial lab in Regina, Saskatchewan.  
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3.3.4 Statistical Analysis 
Nutrient analysis of the weighed food records was performed using Food 
Processor version 8.8.0 for Windows by ESHA Research, Salem, Oregon. Statistics 
were performed using SPSS 14.0 (SPSS Inc. Chicago, IL). Descriptive statistics were 
calculated for subject characteristics, nutrient intakes and serum vitamin levels at 
baseline and 8 weeks post-intervention. A comparison of nutrient intake and serum 
vitamin levels at baseline and 8 weeks was performed using a Wilcoxon Signed Ranks 
test. This non-parametric test is appropriate since the sample size was small and the 
samples are related (i.e. before and after intervention). Prevalence of inadequacy was 
determined at baseline and after the intervention for vitamins with an EAR by using the 
EAR cut-point method (Otten et al., 2006). Scatterplots were made and Spearman’s Rho 
correlation coefficients (the non-parametric equivalent of Pearson correlation 
coefficients) were calculated to determine if a linear relationship existed between 
vitamin B12, folate, and vitamin D intakes and their corresponding serum levels at 
baseline and 8 weeks after the intervention. 
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CHAPTER 4 
RESULTS
4.1 PHASE I - DETERMINATION OF FORTIFICATION LEVELS 
4.1.1 Calculations for Determination of Fortification Levels 
Table 4.1 shows the combined mean intake (± SD) for 6 days of weighed food 
intakes from the previous intake study performed at Parkridge Centre and the calculation 
of EAR + 2SDin (i.e. target intake) for the nutrients that have an EAR. Table 4.2 uses the 
values for the target intake from Table 4.1 as well as the 25% calculation recommended 
by Health Canada to test what the actual nutrient intakes would be using the hypothetical 
fortified foods instead of the unfortified version.  
Using the results in Table 4.2, appropriate fortification levels were determined and 
are shown in Table 4.3. The fortification levels for thiamine, riboflavin, vitamin B6, 
vitamin B12, vitamin C, vitamin E, zinc, selenium, and copper were the rounded values 
calculated by the target intake formula, EAR + 2SDin. The fortification levels for biotin, 
vitamin D, pantothenic acid, chromium, and manganese were determined using 25% of 
the AI because these nutrients do not have an EAR. The fortification levels for niacin, 
calcium, and magnesium were lower than the values calculated by either formula so that 
intakes would not risk exceeding the UL. The values for folate, iron, and molybdenum 
were determined using 25% of the RDA instead of the target intake formula. The target 
intake formula would have risked exceeding the UL for folate. A lower level of iron was 
desired due to the risk of iron changing the flavour of the food so the lower value 
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calculated by 25% of the RDA was chosen instead of the higher target intake value. The 
target intake formula could not be used for molybdenum because the SDin could not be 
determined for this nutrient.  
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Table 4.1 Combined mean intake using 6 days of weighed food records per subject 
and EAR+2SD calculation. 
 
Nutrient Combined nutrient intake 
(mean ± SD) 
Target Intake1 
Thiamin (mg) 
 
0.79 ± 0.34 1.67 
Riboflavin (mg) 
 
1.30 ± 0.51 2.11 
Niacin (mg) 
 
12 ± 4 21 
Vitamin B6 (mg) 
 
1.07 ± 0.60 2.60 
Vitamin B12 (µg) 
 
1.91 ± 1.00 4.01 
Biotin (µg) 
 
29 ± 35 N/A 
Vitamin C (mg) 
 
92 ± 55 185 
Vitamin A (µg RAE) 
 
614 ± 927 Large SD prevents accurate 
calculation 
 
Vitamin D (µg) 
 
2.6 ± 2.7 N/A 
Vitamin E (mg) 
 
0.91 ± 2.23 16.45 
Folate (µg DFE) 
 
167 ± 104 527 
Pantothenic Acid (mg) 
 
3.02 ± 1.51 N/A 
Calcium (mg) 
 
732 ± 2.97 N/A 
Iron (mg) 
 
8.56 ± 4.15 14.3 
Zinc (mg) 
 
4.65 ± 2.32 14.0 
Potassium (mg) 
 
1909 ± 788 N/A 
Magnesium (mg) 
 
127 ± 63 476 
Selenium (µg) 
 
9.13 ± 11.17 67 
Copper (µg) 
 
456 ± 321 1343 
Manganese (µg) 
 
0.96 ± 0.69 N/A 
Abbreviations: SD, standard deviation; N/A, not applicable because nutrient does not have an EAR. 
1Calculated using the formula EAR + 2SDin 
 
 
 
 Table 4.2 Calculations for determination of pureed food fortification levels. 
 RDA1 
(AI) 
UL1 Health Canada 
method2 
Target per 
day3 
Target per 
serving4 
Min. 
intake5 
Max. 
intake6 
“Ideal”  
single portion7 
“Ideal” 
double portion8 
Vitamins          
Thiamine (mg) 1.2 ND 0.3 1.7 0.4 0.1 3.2 2.5 4.6 
Riboflavin (mg) 1.3 ND 0.3 2.1 0.5 0.5 5.5 3.1 5.6 
Niacin (mg) 16 35 4 20 5.2 3.3 27 17 30 
Vitamin B6 (mg) 1.7 100 0.4 2.6 0.6 1.0 6.7 3.7 7.0 
Vitamin B12 (g) 2.4 ND 0.6 4.0 1.0 3.3 5.1 4.7 9.4 
Biotin (µg) (30) ND 7.5 AI  21 182 42 85 
Vitamin C (mg) 90 2000 22.5 185 46 27 450 302 527 
Vitamin D (µg) (15) 50 3.8 AI  6 39 23 41 
Vitamin E (mg) 15 1000 3.8 16 4.1 17 19 19 38 
Folate (µg) 400 1000 100 527 132 21 617 563 1048 
Pantothenic Acid (mg) (5) ND 1.25 AI  0.5 8.9 8.0 15 
Minerals          
Calcium (mg) (1200) 2500 300 AI  383 2290 659 736 
Zinc (mg) 11 40 2.8 14 3.5 1.0 13 16 31 
Magnesium (mg) 420 350 105 476 119 372 873 291 515 
Selenium (µg) 55 400 14 67 17 0.6 152 76 147 
Chromium (µg) (30) ND 7.5 AI  0.3 44 35 70 
Copper (µg) 900 10000 225 1343 336 120 2090 2150 3850 
Manganese (mg) (2.3) 11 0.6 AI  0.03 4.5 3.4 6.0 
Molybdenum (µg) 45 2000 11.25 n/a  0.44 65 51 103 
Iron (mg) 8 45 2 14.3 3.6 1.1 34 16 27 
Abbreviations: RDA, Recommended dietary allowance; AI, adequate intake; UL, tolerable upper intake level; EAR, estimated average requirement; SD, standard deviation; ND, not determined; n/a, not applicable due to incomplete 
food database for calculating SDin from previous food records 
1For adults >70 years 
225% of RDA/AI based on Health Canada’s recommendation for using a defined nutrient contribution 
3Calculation as per DRI recommendation for minimizing nutrient inadequacies (EAR + 2SDin) 
4Amount of fortification required per serving of protein and starch (4 servings per day, 2 of each) calculated as (EAR+2SDin)/4 
5Minimum nutrient intake achieved using food record with lowest intake for the nutrient and substituting fortified food for the equivalent non-fortified food 
6Maximum nutrient intake achieved using food record with highest intake for the nutrient and substituting fortified food for the equivalent non-fortified food 
7Ideal intake assuming all foods on pureed menu were eaten with substitution of one serving of fortified foods for non-fortified equivalents 
8Ideal intake assuming all foods on pureed menu were eaten with substitution of two servings of fortified foods for non-fortified equivalents 
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Table 4.3 Fortification levels for pureed foods. 
 Fortification 
level per 65g 
starch serving1 
Fortification level 
per 90 g meat 
serving1 
Fortification level 
per 100g juice2 
Vitamins    
Thiamine (mg) 0.4 0.4 - 
Riboflavin (mg) 0.5 0.5 - 
Niacin (mg) 1 1 - 
Vitamin B6 (mg) 0.6 0.6 - 
Vitamin B12 (µg) 1 1 - 
Biotin (µg) 7.5 7.5 - 
Vitamin C (mg) 45 45 - 
Vitamin D (µg) 4 4 - 
Vitamin E (mg) 4 4 - 
Folate (µg) 100 100 - 
Pantothenic Acid (mg) 1.25 1.25 - 
Minerals    
Calcium (mg) - - 100 
Zinc (mg) 3 3 - 
Magnesium (mg) - - 75 
Selenium (µg) 15 15 - 
Chromium (µg) 7.5 7.5 - 
Copper (µg) 300 300 - 
Manganese (mg) 0.5 0.5 - 
Molybdenum (µg) 11 11 - 
Iron (mg) 2 2 - 
1Based on four fortified foods served per day (2 starch and 2 meat) 
2Juices are served ad libitum  
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4.1.2 Sensory Testing 
The results from six different triangle tests are summarized in Table 4.4. The 
table shows the type of vitamin and/or mineral formulation added to each puree, the 
number of panelists present at each session, and the number of panelists who could 
correctly distinguish the fortified sample in serving 1 (two control samples and one 
fortified sample) and the control sample in serving 2 (two fortified samples and one 
control sample). Percentages of correct choices are shown in parentheses. Tests that 
were not significant (P > 0.05) are shown in bold and indicate that panelists were not 
able to discriminate between the fortified and unfortified samples in these tests.  
Panelists were able to discriminate between the fortified and unfortifed samples 
in both serving 1 and 2 when the tomato basil bread puree and savoury bread puree was 
fortified with vitamins and minerals with iron. Panelists were able to discriminate 
between the fortified and unfortified samples in serving 1 but not in serving 2 for the 
beef puree fortified with vitamins and minerals with iron, chicken puree with vitamins 
and minerals without iron, and the chicken sandwich and vegetarian pasta purees with 
vitamins only. Because the significance of the tests were different between serving 1 and 
2, it cannot be said conclusively that the fortification did not change the flavour in these 
samples but that these food/micronutrient combinations most likely minimize flavour 
changes caused by the fortification powder. The effect fortification has on flavour 
appears to depend not only on the vitamin/mineral composition of the fortification 
powder but also on the food product to which the powder was added. For example, iron 
appears to have the greatest impact on changing the flavour except when added to beef. 
Thus, in order to minimize the chance of the fortification powder changing the flavour of 
the food, fortification was performed with vitamins only in the fortification trial. 
    Table 4.4 Sensory testing of fortified pureed foods using triangle tests. 
   Items in bold indicate that there was not a significant difference in taste between the fortified and unfortified samples. 
     
Serving 1 
(1 Fortified Sample, 2 Controls) 
Serving 2 
(1 Control, 2 Fortified Samples) 
Pureed Food Formulation Added # of Panelists # Correctly 
Identified Odd 
Sample (%) 
Significance # Correctly 
Identified Odd 
Sample (%) 
Significance 
Tomato Basil 
Bread Puree 
 
Vitamin/Mineral blend 
with Iron 
28 21 (75) P < 0.001 20 (71) P  < 0.001 
Beef Puree Vitamin/Mineral blend 
with Iron 
 
25 14 (56) P  = 0.016 7 (28) P = 0.778 
Savoury Bread 
Puree 
 
Vitamin/Mineral blend 
with Iron 
26 15 (58) P  = 0.009 16 (62) P  = 0.003 
Chicken Puree Vitamin/Mineral blend 
Without Iron 
 
21 12 (57) P  = 0.021 10 (48) P = 0.125 
Chicken 
Sandwich/ 
Vegetarian Pasta 
Puree 
 
Vitamin formulation 
only  
21 12 (57) P  = 0.021 9 (43) P = 0.240 
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4.2 PHASE II - FORTIFICATION TRIAL OF PUREED FOODS 
To ensure that the decision to fortify the vegetables instead of the starch products 
still provided adequate nutrient levels without excessive intakes, the calculations 
completed in Table 4.2 were performed again, making the substitutions with the 
hypothetical fortified vegetables for the unfortified vegetables. The comparison of 
nutrient intakes using starch products versus vegetables is shown in Table 4.5 and shows 
that fortifying the vegetables instead of the starch would result in nutrient intakes at 
almost the same level.  
Subject characteristics are shown in Table 4.6. Of the 11 subjects that completed 
the study, nine were female and two were male. Subject 6 was the subject for which 
weighed food intakes were not completed. Five of the subjects received vitamin and/or 
mineral supplements. The body mass index (BMI) range was quite wide at 19 – 33 
kg/m2. The ideal BMI range associated with maximum life expectancy appears to 
increase with age with the lower end of the range being 22 – 23 kg/m2 and the upper end 
at 27 – 28 kg/m2 (Chapman, 2006). Three of the eleven subjects had a BMI < 22 and 
three subjects had a BMI ≥ 28. Subject 1 received a 1200 µg/d vitamin B12 supplement 
which explains her very high serum vitamin B12 concentration. The composition of the 
multivitamin provided to some residents at Parkridge Centre is shown in Table 4.7. 
Table 4.8 shows the medications used by participants.  
Analysis of the fortification powder found that the actual content per 100 mg was 
4.1 µg vitamin D, 1.1 µg vitamin B12, and 104 µg folic acid. These values were close to 
the labeled content as shown in Table 3.2. Table 4.9 shows baseline and intervention 
intakes for energy, protein, and vitamins from food (excluding supplements) as well as 
the EAR, RDA/AI, and UL for each nutrient for comparison of adequacy. Intakes for all 
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of the vitamins increased as a result of the fortification (P < 0.05); protein and energy 
intakes did not change. Prior to the intervention there was a prevalence of inadequacy of 
at least 10% for all vitamins except niacin. After the intervention, the prevalence of 
inadequacy was zero for all vitamins except vitamin B6 (Table 4.10).  
Table 4.11 shows the serum concentrations of vitamin B12, folate, and 25(OH)D at 
baseline and 8 weeks after the fortified foods were included on the pureed menu. Prior to 
the intervention, all participants had serum vitamin B12 concentrations above the 
borderline deficiency cut-off value of 138 pmol/L. Serum vitamin B12 levels did not 
change after the intervention (P = 0.386). Serum folate concentrations significantly 
increased after the intervention (P = 0.003). At baseline, 64% of participants had a 
serum folate level below the deficiency cut-off value of 11.8 nmol/L. After the 
intervention, all participants had serum folate levels above 11.8 nmol/L. Serum 
25(OH)D concentrations also significantly increased after the intervention (P = 0.003). 
Prevalence of serum 25(OH)D insufficiency at baseline was 55% (defined as serum 
25(OH)D < 40 nmol/L), which was reduced to zero after the intervention. 
Scatterplots for the relationships between vitamin intake and serum vitamin 
concentration are shown in figures 4.1 – 4.6. There was a significant correlation between 
vitamin D intake and serum 25(OH)D levels at baseline (rs = 0.857, P = 0.002) but not 
after the intervention (rs  = 0.444, P = 0.198). Serum vitamin B12 and folate did not show 
a significant correlation with intake (Table 4.12). No side effects attributed to the 
fortification were reported to the research team by the residents receiving the fortified 
pureed foods, family members of the residents, or the staff at Parkridge Centre. 
 
 Table 4.5 Comparison of nutrient intakes resulting from fortification of starch servings vs. vegetable servings. 
 
 Nutrient intakes with starch servings fortified Nutrient intakes with vegetable servings fortified 
 Min. 
intake1 
Max. 
intake2 
“Ideal”  
1 svg3 
“Ideal” 
2 svg4 
Min. 
intake1 
Max. 
intake2 
“Ideal”  
1 svg3 
“Ideal” 
2 svg4 
Vitamins         
Thiamine (mg) 0.1 3.2 2.5 4.6 0.1 3.2 2.2 3.9 
Riboflavin (mg) 0.5 5.5 3.1 5.6 0.5 5.4 2.8 4.9 
Niacin (mg) 3.3 27.5 17.1 30.5 2.4 27.3 16.4 27.1 
Vitamin B6 (mg) 1.0 6.7 3.7 7.0 1.0 6.6 3.3 5.8 
Vitamin B12 (µg) 3.3 5.1 4.7 9.4 2.1 4.7 4.0 8.0 
Biotin (µg) 21 181 42 85 21 180 42 84 
Vitamin C (mg) 27 450 302 527 26 450 271 462 
Vitamin D (µg) 6 39 23 41 9 37 20 36 
Vitamin E (mg) 17 19 20 39 10 16 17 33 
Folate (µg) 21 617 563 1048 21 601 495 914 
Pantothenic Acid (mg) 0.5 8.9 8.0 15.1 0.5 8.7 7.2 12.3 
Minerals         
Calcium (mg) 383 2290 659 736 383 2290 659 736 
Zinc (mg) 1.0 12.9 16.0 30.6 1.0 12.4 13.9 26.3 
Magnesium (mg) 372 873 291 515 372 873 291 515 
Selenium (µg) 0.6 152 76 147 0.6 148 66 126 
Chromium (µg) 0.3 44 35 70 0.3 42 23 45 
Copper (µg) 120 2090 2150 3850 120 2050 1950 3220 
Manganese (mg) 0.03 4.5 3.4 6.0 0.03 4.4 3.0 5.3 
Molybdenum (µg) 0.4 65 51 103 0.4 62 33 66 
Iron (mg) 1.1 34.0 16.0 27.5 1.1 33.4 14.6 25.4 
1Minimum nutrient intake achieved using food record with lowest intake for the nutrient and substituting fortified food for the equivalent non-fortified food 
2Maximum nutrient intake achieved using food record with highest intake for the nutrient and substituting fortified food for the equivalent non-fortified food 
3Ideal intake assuming all foods on pureed menu were eaten with substitution of one serving of fortified foods for non-fortified equivalents 
4Ideal intake assuming all foods on pureed menu were eaten with substitution of two serving of fortified foods for non-fortified equivalents 
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 Table 4.6 Subject characteristics. 
 
 
Subject Age 
(years) 
BMI 
(kg/m2) 
Length of 
Stay (years)
Primary Diagnoses Daily Supplement Use 
1 80 19 7 Schizophrenia, Alzheimer’s Disease Calcium 1300 mg 
Multivitamin 
Vitamin B12 1200 µg 
2 69 21 2 Alzheimer’s Disease - 
3 70 30 3 Vascular Dementia / Alzheimer’s Disease - 
4 81 23 7 Dementia - 
5 81 28 7 Alzheimer’s Dementia Calcium 500 mg 
6 81 33 2 Cerebral Vascular Accident, Congestive 
Heart Failure 
- 
7 62 21 8 Alzheimer’s Disease Calcium 500 mg 
8 78 25 5 Alzheimer’s Disease - 
9 70 27 3 Schizophrenia, Paranoid - 
10 54 26 3 Huntington’s Chorea, Depression Multivitamin 
11 79 25 6 Dementia, Parkinson’s,  
Angina 
Multivitamin 
Mean ± SD 73 ± 9 25 ± 4 5 ± 2   
Range 54 - 81 19 - 33 2 - 8   
Abbreviations: BMI, body mass index 
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Table 4.7 Composition of multivitamin provided to residents. 
 
Vitamin Amount 
Vitamin A 1500 µg RAE (5000 IU) 
Vitamin C 50 mg 
Vitamin B1 (Thiamin) 3 mg 
Vitamin B2 (Riboflavin) 2.5 mg 
Vitamin B6 1 mg 
Vitamin B12 3 µg 
Vitamin D3 10 µg 
Niacinamide 20 mg 
Abbreviations: RAE, retinol activity equivalent; IU, International Units 
 
Table 4.8 Prescription1 medication use by residents. 
 
Subject Daily Prescription Medications 
1 Clonazepam Seroquel Hydroxyzine 
2 Carbamazepine 
Lorazepam (Ativan) 
Risperidone 
Seroquel 
Sertraline 
 
3 Eltroxin Mirtazapine Risperidone 
4 Citalopram 
Clonazepam 
Eltroxin 
Lorazepam (Ativan) 
Seroquel 
 
5 Lorazepam (Ativan) 
Citalopram 
Glyburide 
Indapamide 
Metformin 
Ranitidine 
Seroquel 
 
6 Citalopram 
Lipitor 
Metoprolol 
Pariet 
Warfarin 
 
7 Baclofen 
Carbamazepine 
Clonazepam 
Fentanyl 
 
Venlafaxine 
 
8 Hydromorphone (Dilaudid) 
Lorazepam (Ativan) 
Seroquel Trazodone 
Ranitidine 
9 Seroquel 
Ramipril 
Plavix 
Lasix 
Viaderm 
Salbutamol ventalin 
Hydroxyzine 
Clopixol 
Flonase 
Lotriderm 
Benztropine 
10 Paroxitine 
Risperidone 
Seroquel Lorazepam (Ativan) 
 
11 Lorazepam (Ativan) 
Selegiline 
Seroquel  
1Does not include over-the-counter medications or laxatives. 
Drugs in bold indicate those that potentially interact with folate and/or vitamin B12  
 
 Table 4.9 Energy, protein and vitamin intakes from food of long-term care residents consuming a pureed diet (n=10). 
 
 Baseline 
(mean ± SD) 
Intervention 
(mean ± SD) 
P-Value EAR1 RDA 
(AI)1 
UL1 
Energy (kcal) 1272 ± 257 1265 ± 253 0.5 ND ND ND 
Protein 46 ± 12 46 ± 10 0.65 45 g/d 
(0.66 g/kg/d) 
54 g/d 
(0.80 g/kg/d) 
ND 
Thiamin (mg) 0.8 ± 0.3 1.7 ± 0.3 0.005 1.0 1.2 ND 
Riboflavin (mg) 1.2 ± 0.4 2.2 ± 0.4 0.005 1.1 1.3 ND 
Niacin (NE) 19 ± 5 24 ± 6 0.007 12 16 35 
Vitamin B6 (mg) 1.6 ± 0.6 2.7 ± 0.6 0.007 1.4 1.7 100 
Vitamin B12 (µg) 3.4 ± 1.2 5.1 ± 1.4 0.007 2.0 2.4 ND 
Vitamin C (mg) 151 ± 78 228 ± 67 0.007 75 90 2000 
Vitamin D (µg) 2.1 ± 2.2 12.2 ± 3.3 0.005 -- (15) 50 
Folate (µg DFE) 114 ±58 505 ± 86 0.005 320 400 10002 
Pantothenic Acid (mg) 3.1 ± 1.1 5.7 ± 1.0 0.005 -- (5) ND 
Abbreviations: DFE, dietary folate equivalent; NE, niacin equivalents; ND, not determined 
1Highest value for males and females >70 years. 
2Applies only to synthetic forms from supplements and/or fortified foods. 
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 Table 4.10 Prevalence of inadequacy1 at baseline and after intervention for vitamins with an EAR (n=10). 
 
Vitamin Prevalence of inadequacy at baseline (%) Prevalence of inadequacy after intervention (%) 
Thiamin 80 0 
Riboflavin 30 0 
Niacin 0 0 
Vitamin B6 20 10 
Vitamin B12 10 0 
Vitamin C 10 0 
Folate 100 0 
1Prevalence of inadequacy = # of participants with vitamin intake below EAR/total # of participants 
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 Table 4.11 Serum concentrations of vitamin B12, folate and 25(OH)D at baseline and 8 weeks after intervention. 
 
Subject Serum Vitamin B12 (pmol/L) Serum Folate (nmol/L) Serum 25(OH)D (nmol/L) 
 Baseline Intervention Baseline Intervention Baseline Intervention 
1 >1476 >1476 21.2 37.9 71 75 
2 371 562 7.4 19.4 29 71 
3 205 271 8.0 20.6 44 59 
4 382 545 15.0 32.2 51 76 
5 548 508 10.7 20.4 21 63 
6 861 508 15.4 26.3 33 56 
7 273 350 6.5 25.5 16 58 
8 290 319 13.6 32.7 14 52 
9 359 352 6.2 21.6 34 58 
10 578 522 7.6 18.9 71 80 
11 492 545 6.4 21.2 64 82 
Mean ± SD 436 ± 1922 448 ± 1112 10.7 ± 4.9 25.2 ± 6.4 41 ± 21 66 ± 11 
P-value3 0.386 0.003 0.003 
Range 205 - 1476 271 - 1476 6.2 – 21.2 18.9 – 37.9 14 – 71 52 - 82 
% Deficient/ 
Insufficient 
0 0 64 0 55 0 
Normal Values1 Deficient: <116 
Borderline: 116-138 
Normal: 138-781 
>11.8 Deficient: <25 
Insufficient: <40 
Toxic: >250 
1Normal values are those used by the medical laboratories where the samples were analyzed. 
2Subject 1 excluded from calculation since value is an outlier. 
3Comparison of baseline vs. intervention using Wilcoxon Signed Ranks test. 
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Table 4.12 Correlation coefficients for serum vitamin levels vs. vitamin intakes 
from food and supplements (n=10)1. 
 
 Correlation  
coefficient (rs) 
P-value 
Baseline   
Vitamin B12 intake – Serum vitamin B12 0.234 0.544 
Folate intake – Serum folate 0.158 0.663 
Vitamin D intake – Serum vitamin D 0.857 0.002 
Intervention   
Vitamin B12 intake – Serum vitamin B12 0.117 0.764 
Folate intake – Serum folate 0.164 0.651 
Vitamin D intake – Serum vitamin D 0.444 0.198 
1n = 9 for vitamin B12 correlations due to removal of outlier 
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Figure 4.1 Association of baseline vitamin B12 intake from food 
and supplements with baseline serum vitamin B12 levels1. 
1Outlier excluded (serum vitamin B12 >1476 pmol/L; vitamin B12 intake 1206 µg/day) 
1Outlier excluded (serum vitamin B12 >1476 pmol/L; vitamin B12 intake 1207 µg/day) 
Figure 4.2 Association of intervention vitamin B12 intake from food 
and supplements with intervention serum vitamin B12 levels1. 
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Figure 4.3 Association of baseline folate intake from food  
and supplements with baseline serum folate levels. 
Figure 4.4 Association of intervention folate intake from food  
and supplements with intervention serum folate levels. 
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Figure 4.5 Association of baseline vitamin D intake from food  
and supplements with baseline serum 25(OH)D levels. 
Figure 4.6 Association of intervention vitamin D intake from food  
and supplements with intervention serum 25(OH)D levels. 
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CHAPTER 5 
DISCUSSION
 
5.1 DETERMINATION OF FORTIFICATION LEVELS 
 This study demonstrates that the DRI menu planning calculation for target intake 
(EAR + 2SDin) in combination with the Health Canada fortification guidelines (Health 
Canada, 2005) are useful methods for determining appropriate fortification levels. 
Vitamin intakes of residents consuming a pureed diet in a LTC facility increased as a 
result of the fortification and the mean group intakes increased above the EAR for all 
nutrients after the intervention, but did not exceed the UL. One of the disadvantages of 
the DRI menu planning method is that it can only be used for nutrients with an EAR, not 
for those with an AI. In addition to using the DRI menu planning method, we used a 
defined nutrient contribution of 25% to calculate the fortification level based on the 
Health Canada guidelines. For several of the vitamins (thiamine, riboflavin, vitamin B6, 
vitamin B12 and vitamin C) the final fortification level was the value calculated from the 
DRI equation. If only the Health Canada method was used to determine fortification 
levels, the fortification may not have raised nutrient intakes sufficiently to decrease the 
prevalence of inadequacy. On the contrary, if only the DRI equation had been used, the 
fortification levels may have resulted in excessive intakes for some vitamins (e.g. 
niacin), which is why using a combination of both methods is beneficial. This study 
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shows the value of the DRI menu planning calculation and emphasizes the need for 
developing EAR/RDAs for the nutrients for which only an AI is currently available. 
 The results of the sensory testing allowed the decision to be made to use vitamins 
only in the fortification powder in order to minimize flavour changes. Meat products 
appeared to mask the flavour changes best. Of interest is that sensory panelists were less 
likely to detect a difference between the control and fortified samples when given one 
control and two fortified samples instead of two controls and one fortified sample. 
 
5.2 FORTIFICATION TRIAL 
 The principal finding of this phase of the study was that vitamin fortification of 
pureed foods for residents in long-term care is a promising method for improving 
nutritional status. Serum folate and 25(OH)D concentrations increased for all 
participants, from a mean (± SD) concentration of 10.7 ± 4.9 to 25.2 ± 6.4 nmol/L for 
serum folate (P = 0.003), and 41 ± 21 to 66 ± 11 nmol/L for 25(OH)D (P = 0.003). 
Serum vitamin B12 levels did not change (P = 0.386) which may be due to a threshold 
effect since none of the participants had insufficient levels at baseline.  
 An advantage of using food fortification to treat micronutrient malnutrition is 
that compliance with the treatment is guaranteed, as long as the residents consume the 
food, whereas compliance with using vitamin/mineral supplements can be low. A two 
year double-blind, randomized control trial examined whether vitamin D 
supplementation can reduce the incidence of falls and fractures in elderly LTC residents 
(Flicker, MacInnis, Stein, Scherer, Mead, & Nowson, 2005). Institutional staff was 
responsible for providing the supplements to the study participants. The results of the 
study showed that 14% of the subjects had a compliance of 50% or less, which 
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demonstrates that even when supplements are included as part of the medical care of 
LTC residents, compliance can be low. 
 Using weighed food records performed by research assistants for dietary 
assessment was appropriate for this study since all of the participants except one were 
cognitively impaired, which would have made it very difficult to use any other dietary 
assessment method. The results of the dietary assessment showed that energy and 
protein intakes did not change while nutrient intakes significantly increased (Table 4.9). 
Energy intakes appeared to be quite consistent in this population at about 1200 kcal/day 
based on the current study and our previous study (Adolphe et al., 2006). Because 
elderly people in LTC consuming a pureed diet are often inactive, they may have lower 
energy requirements than those who are more mobile, but it is still important that their 
micronutrient needs are met. Since energy intakes did not change after the intervention, 
it appears that the fortified foods were as acceptable as the unfortified foods. However, 
the fortification trial was not designed to specifically look at food acceptability. 
Residents in the study were served consistent portions of food and were usually fed by a 
caregiver. These factors may have affected the amount that they ate so a definite 
conclusion about food acceptability cannot be made. Nevertheless, fortification appears 
to be a good solution to micronutrient malnutrition for this population. 
 Although dietary assessment is an important tool to use to determine if 
individuals and groups are ingesting sufficient levels of micronutrients, biochemical 
measurements are needed to determine the micronutrient status of an individual. Serum 
25(OH)D, vitamin B12, and folate were chosen as indicators of nutritional status in this 
study because not only are they vitamins of concern in this population, but there are 
biochemical tests available to determine their status (Health Canada, 2006). These 
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vitamins appear to be good indicators of nutritional status in this population and the 
increase in serum levels found in this study suggest that the bioavailability of vitamin D 
and folate is good from pureed meat and vegetables. Although an increase in serum 
vitamin B12 was not observed, likely due to adequate levels at baseline, the 
bioavailability of vitamin B12 from these foods should also be satisfactory. 
 There are several methods available to quantify serum folate, including 
microbiological methods, assays using folate-binding proteins, and chromatographic 
techniques, but chemiluminescence detection methods are currently the most commonly 
used (Owen & Roberts, 2003). The samples obtained in the present study were analyzed 
by a medical laboratory that used a Roche E170 electrochemiluminescence 
immunoassay. This system is based on the technology used by the older Roche Elecsys 
2010 system (Wan, Augustin, Chan, Leblond, Verjee, & Adeli, 2005). A study by Owen 
& Roberts (2003) showed that of five automated folate analysis methods, the Elecsys 
2010 and ARCHITECT I2000 demonstrated the best linearity. However, the study also 
showed that the Elecsys 2010 may have a higher degree of imprecision (16%) than some 
of the other methods (10%) at low folate concentrations. This could have possibly 
affected our baseline results since some of the baseline samples had low serum folate 
concentrations. However, the serum folate levels found at baseline are not surprising 
given the very low dietary folate intake in our sample at baseline (114 ± 58 µg/d).  
 Several methods are available to determine 25(OH)D concentrations. High-
performance liquid chromatography (HPLC) is generally considered to be the gold 
standard method, but it is a cumbersome procedure that is not suited for high output 
clinical laboratories (Hollis & Horst, 2007). However, liquid chromatography-mass 
spectrometry (LC-MS), the method used in the present study, is a suitable alternative to 
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HPLC. When properly performed, LC-MS is a very accurate method and the fact that 
25(OH)D is highly hydrophobic is not a major factor when using this technique (Hollis 
& Horst, 2007). One of the problems that may affect LC-MS results is that the method is 
unable to discriminate between 25(OH)D3 and the inactive isomer 3-epi-25(OH)D3. 
However, this is a problem primarily in newborns (Hollis & Horst, 2007) and thus 
should not have affected the results from our elderly study population.  
 A possible disadvantage of using chemiluminescence to determine serum vitamin 
B12 levels is that levels can be overestimated if the samples are not handled properly. 
One study found that using serum separator tubes resulted in elevated serum vitamin B12 
levels if additional sample preparation (i.e. centrifugation) did not occur prior to analysis 
using a Bayer Centaur chemiluminescence method (Lowrey & Smith, 2003). However, 
in the study by Lowrey & Smith (2003), the samples were transported from distant 
locations which could result in changes in the sample from time of withdrawal to 
analysis, while in our study the samples were analyzed within the same city. 
 There is currently not a definitive cut-off value for vitamin B12, folate, and 
vitamin D deficiencies. Current research is suggesting that cut-off values for these 
vitamins may be higher than previously thought. Optimal vitamin D status has recently 
been defined as a serum 25(OH)D value of ≥ 90 nmol/L (Bischoff-Ferrari et al., 2006; 
Heaney, 2006; Whiting et al., Submitted June 1, 2007). The lower limit for vitamin B12 
may be as high as 258 pmol/L (L. H. Allen & Casterline, 1994) and for folate a value of 
10-15 nmol/L may be ideal (Hultberg et al., 2002). Because the serum samples in the 
present study were analyzed in off-site medical laboratories, the cut-off values used to 
determine the participants’ deficiency status were those provided by the laboratories. 
The reference value from the lab for serum folate (> 11.8 nmol/L) was within the ideal 
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range suggested in the literature but the lab reference values for serum vitamin B12 
(normal ≥ 138 pmol/L) and 25(OH)D (normal ≥ 40 nmol/L) were lower than those 
reported in the literature. Using the values provided by the lab, the deficiency rate at 
baseline was zero for serum vitamin B12 and 55% for serum 25(OH)D and none of the 
participants were considered deficient for either vitamin after the intervention. However, 
if the higher cut-off values of 258 pmol/L for vitamin B12 and 90 nmol/L for 25(OH)D 
suggested in the literature were used to determine deficiency rates, the deficiency rates 
in the present study would have been 9% for serum vitamin B12 and 100% for serum 
25(OH)D at baseline. Still using the higher cut-off values, the prevalence of serum 
vitamin B12 deficiency after the intervention would have decreased to zero while the 
prevalence of serum 25(OH)D deficiency would have remained at 100%. This 
demonstrates that determining the prevalence of deficiency using serum vitamin levels 
can be highly dependent on the reference values used.  
 Even when the higher cut-off value suggested in the literature is used for 
determining vitamin B12 deficiency, the prevalence of deficiency in the present study 
was low. This was surprising since the literature indicates a relatively high prevalence of 
cobalamin deficiency in the institutionalized elderly (Andres et al., 2004). There is no 
obvious explanation for this other than that our sample size was relatively small. One of 
the subjects had very high serum cobalamin levels due to a large daily oral dose of 
vitamin B12. This may indicate a heightened awareness among the geriatricians, who 
care for the residents in this facility, that testing and subsequent treatment for cobalamin 
deficiency is important for this population. There is also the possibility that the methods 
used to analyze the serum samples overestimated the concentrations, as discussed above.  
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 Although an improvement in serum 25(OH)D status was observed after the 
intervention, the fortification level was not high enough to achieve an optimal 25(OH)D 
status of ≥ 90 nmol/L in any of the participants. An additional 10 µg of vitamin D was 
added daily to the food. The mean difference in vitamin D intake from baseline to after 
the intervention (from fortification powder and other food sources) was 10.1 µg/day. 
This increased vitamin D intake resulted in a mean serum 25(OH)D level of 66 nmol/L 
after the intervention, an increase of 25 nmol/L from baseline. Other studies have also 
reported large increases in serum 25(OH)D in response to 10 µg of vitamin D 
supplementation. Ooms, Roos, Bezemer, van der Vijgh, Bouter, and Lips (1995) found 
an increase of 35 nmol/L (baseline 27 nmol/L; intervention 62 nmol/L) after one year of 
supplementation. A recent study by Holvik, Madar, Meyer, Lofthus, and Stene (2007) 
also found a similar response after four weeks of supplementation with 10 µg of vitamin 
D from a multivitamin tablet or fish oil capsule in subjects aged 19-49 years. Baseline 
serum 25(OH)D was 40.3 nmol/L in the multivitamin group and 48.5 nmol/L in the fish 
oil group. The mean 25(OH)D concentration increased by 36 nmol/L in the multivitamin 
group and 32 nmol/L in the fish oil group.  
 However, some studies have not shown such a large increase in 25(OH)D in 
response to modest vitamin D supplementation. A study by Viljakainen et al. (2006) 
found that a 10 µg vitamin D supplement increased serum 25(OH)D levels from 46.5 to 
60 nmol/L in six weeks, a difference of only 13.5 nmol/L. This is likely not due to the 
short duration of the study since the authors reported that 25(OH)D levels reached a 
plateau at 6 weeks. Pfeifer, Begerow, Minne, Nachtigall, and Hansen (2001) found an 
increase of 39 nmol/L (baseline 26 nmol/L; intervention 65 nmol/L) after eight weeks of 
supplementation, but this resulted from supplementation with 20 µg of vitamin D. The 
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results from our study showed a 2.5 nmol/L increase of 25(OH)D per 1 µg of vitamin D. 
Heaney et al. (2003) reported on several studies for which the relationship between 
25(OH)D and vitamin D supplementation could be calculated and found a range from 
0.56 nmol/L per 1 µg of vitamin D to as high as 5.5 nmol/L per 1 µg of vitamin D. It is 
uncertain exactly what factors impact this relationship, though baseline 25(OH)D status 
appears to have an effect. Nevertheless, the results from the present study are situated 
within the range reported by Heaney et al. (2003). 
 Mean folate intake increased from 114 µg DFE/day at baseline to 505 µg 
DFE/day after the intervention, a difference of 391 µg DFE/day. Baseline mean serum 
folate concentration was 10.7 nmol/L which increased to 25.2 nmol/L after the 
intervention, a difference of 14.5 nmol/L. Other studies have found similar dose-
responses to folic acid fortification. A study by van Vliet (2007) found similar responses 
to 400 µg of folic acid which was provided via a fortified spread that was consumed 
daily for six weeks. In males, serum folate concentrations increased from 15.8 nmol/L to 
29.8 nmol/L, a rise of 14 nmol/L. Females showed an increase of 16.5 nmol/L, from a 
mean baseline level of 13.7 nmol/L to 30.2 nmol/L after the intervention. Venn et al. 
(2002) found that after four weeks of consuming a breakfast cereal fortified with 300 µg 
of folic acid, serum folate levels increased by 15 nmol/L, from a baseline concentration 
of 18 nmol/L to 33 nmol/L after the intervention.  
 There was a correlation between vitamin D intake and serum 25(OH)D at 
baseline (rs  = 0.857; P = 0.002) but not after the intervention (rs  = 0.444; P = 0.198). 
Although this study was originally planned to take place during the winter but was 
delayed due to unforeseen circumstances until the spring, to the best of our knowledge 
participants were not exposed to sunlight during the study. The correlations for serum 
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folate and folate intake, and serum vitamin B12 and vitamin B12 intake were not 
significant which may indicate confounding factors that affect these relationships. One 
possible confounder in this study was drug-nutrient interactions. As shown in Table 4.8, 
metformin, which was prescribed to one participant, is known to decrease vitamin B12 
and folate status (Wulffele et al., 2003). Two participants were prescribed ranitidine, one 
of which was the participant also taking metformin, which is known to decrease vitamin 
B12 absorption (Pronsky, 2000).  
 
5.3 IMPLICATIONS FOR DIETETIC PRACTICE 
 The feasibility of on-site fortification was assessed as part of this study. During 
the eight weeks of the fortification trial, a graduate student or research assistant visited 
the facility daily to add the fortification powder to the food. It took approximately one 
hour each day to fortify the four pureed foods. It is not feasible for foodservice staff to 
fortify the pureed foods because of the extra time required. It is also important, from a 
safety perspective, to ensure that the correct amount of fortification powder is added to 
the food. This can be difficult to guarantee in large institutional kitchens where different 
workers are continuously filling different work shifts. Figuring out the logistics of how 
and when to add the fortification powder during production can also be a challenge. It 
would be ideal for the food to be fortified during manufacturing. However, this would 
require facilities to purchase commercially-prepared pureed foods, and facilities that still 
make their own pureed foods may be resistant to this change. 
 The multivitamin offered to residents at Parkridge did not contain all vitamins 
and did not even contain folate. This was surprising to the investigators considering the 
wide variety of broad spectrum multivitamins currently available on the market. 
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Multivitamins may be used by physicians as reassurance that their patients are receiving 
adequate micronutrients. It is important for physicians and other health professionals to 
be aware that not all multivitamin preparations are the same. In addition, unless a 
multivitamin/mineral preparation is specifically requested in the physician’s orders, 
minerals were not included in the micronutrient supplement offered at Parkridge Centre. 
 A community meal service model is used at Parkridge Centre whereby heated 
foodservice carts are used on each ward to serve the residents. This method offers 
several advantages over tray service. It allows residents to choose what they want to eat 
at the time of the meal instead of days, or even weeks, beforehand. It also allows 
residents to request an additional serving of food if desired. Observations made while 
the weighed food records were performed on two of the facility’s wards was that many 
of the study participants were consuming all of their meals, yet the caregiver who was 
assisting the resident with eating did not return to the foodservice cart for an additional 
serving. Because the participants were unable to communicate their desire for more 
food, it is unknown whether or not the amount that they were receiving was adequate to 
satisfy their hunger, or if they would eat more if given the chance. Second helpings 
could increase their energy, protein, and micronutrient intakes. 
 
5.4 LIMITATIONS 
 There are limitations to this study. Subjects were recruited from only one long-
term care facility and the sample size was small. It was difficult to recruit a large sample 
size for this study for several reasons. Only one of the participants was able to consent 
for herself; family consented for the other participants. In some cases, it was difficult to 
get in contact with the family, and several family members did not want to provide 
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consent for various reasons. Another factor that resulted in the small sample size was the 
limitation of trying to recruit from as few wards as possible in order to make it feasible 
to perform the weighed food intakes. 
 Originally it was planned that meats and starches would be fortified so these 
were the products used in the sensory testing. However, for logistical reasons, vegetables 
were fortified in the fortification trial instead of starches. It is not anticipated that this 
would have affected the acceptance of the foods because vegetables tend to be more 
flavourful than starches and would likely mask any flavour changes due to fortification 
better than starches. 
 
5.5 CONCLUSION 
 This study has provided the first evidence that vitamin fortification of pureed 
foods for long-term care residents is an effective method for improving nutritional status 
in a population that is at high risk for malnutrition. The positive results of this study 
provide evidence for food manufacturers to develop and seek regulatory approval for 
fortified pureed foods. 
 
5.6 FUTURE RESEARCH 
 The fortification trial was a pilot study and a larger, multi-centre study needs to 
be performed. Since the pilot study determined that on-site fortification of pureed foods 
is quite labour intensive and not very practical, the larger study should use foods that 
have been fortified during the manufacturing process. 
 This study measured three biomarkers of nutritional status: serum 25(OH)D; 
serum vitamin B12; and serum folate. Future studies should assess the effect of 
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fortification on other health indicators that are relevant to improving the health and 
quality of life of the elderly. Such indicators could include homocysteine, cognitive 
function, incidence of cardiovascular disease and cancer, quality of life, incidence of 
decubitus ulcers, and functional ability. 
 Based on the results of sensory testing, the fortification trial only used vitamins 
to fortify the pureed food. Since food intakes are low in this population, it would be 
ideal to be able to fortify using a broad spectrum of vitamins and minerals that does not 
result in detectable flavour changes. One possible way to achieve this is by using 
microencapsulated minerals. It may be especially important to use microencapsulated 
iron since it seems to negatively affect the flavour. However, microencapsulation would 
increase the cost of fortification and a cost feasibility study of using microencapsulated 
nutrients should be performed. 
 In the present study, vitamin K was excluded from the fortification powder. 
However, in future studies it may be valuable to consider adding vitamin K. It is 
important that the level of vitamin K consumed is consistent in people prescribed drugs 
such as warfarin (Rohde, de Assis, & Rabelo, 2007). Vitamin K supplementation in 
patients prescribed warfarin may help to improve anticoagulation control in patients with 
an unstable response to warfarin (Sconce, Avery, Wynne, & Kamali, 2007). 
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Dietary Intake Data from Previous Long-Term Care Study 
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Table A1 Nutrient intake of long-term care residents consuming a pureed 
diet at baseline and at week eight. 
 
 Nutrient Intake at 
Baseline 
(mean ± SD) 
Nutrient Intake at 
Week Eight 
(mean ± SD) 
Energy (kcal) 1340 ± 402 1244 ± 443 
Protein (g) 49 ± 21 43 ± 15 
Thiamin (mg) *0.7 ± 0.3 *0.9 ± 0.4 
Riboflavin (mg) 1.3 ± 0.5 1.3 ± 0.6 
Niacin (mg) *13 ± 5 *12 ± 4 
Vitamin B6 (mg) *1.2 ± 0.7 *1.0 ± 0.5 
Vitamin B12 (µg) *2.0 ± 1.1 *1.8 ± 0.9 
Vitamin C (mg) 95 ± 60 *89 ± 51 
Vitamin A (µg RAE) *874 ± 1250 *354 ± 227 
Vitamin D (µg) *5 ± 7 *6 ± 4 
Vitamin E (mg) *1 ± 1 *1 ± 3 
Folate (µg DFE) *164 ± 103 *170 ± 103 
Pantothenic Acid (mg) *3 ± 2 *3 ± 2 
Calcium (mg) *719 ± 313 *745 ± 288 
Iron (mg) 8 ± 5 9± 4 
Zinc (mg) *4.7 ± 2.6 *4.6 ± 2.0 
Potassium (mg) *2108 ± 859 *1711 ± 668 
Magnesium (mg) *122 ± 64 *122 ± 63 
Abbreviations: RAE, retinol activity equivalent; DFE, dietary folate equivalent.   
*Indicates mean vitamin/mineral intake is below the Recommended Dietary Allowance  
or Adequate Intake (highest value for males and females >70 years). 
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APPENDIX B 
Nutrient Intake from Food and Supplements for Individual Participants 
 
 Table B1(a) Mean (±SD) vitamin intakes at baseline and 8 weeks after intervention from food and daily vitamin supplement intake per subject 
(subjects 1-6). 
 
 1 2 3 4 5 6 
Thiamin (mg) 
Baseline 
Intervention 
Supplement 
 
0.7 ± 0.2 
1.6 ± 0.2 
3 
 
1.3 ± 0.5 
1.9 ± 0.3 
- 
 
1.0 ± 0.1 
1.9 ± 0.2 
- 
 
0.7 ± 0.1 
1.6 ± 0.2 
- 
 
0.8 ± 0.8 
1.5 ± 0.4 
- 
 
ND 
ND 
- 
Riboflavin (mg) 
Baseline 
Intervention 
Supplement 
 
1.2 ± 0.2 
2.0 ± 0.6 
2.5 
 
1.7 ± 0.2 
2.6 ± 0.5 
- 
 
1.7 ± 0.1 
2.8 ± 0.2 
- 
 
1.2 ± 0.1 
2.2 ± 0.1 
- 
 
0.7 ± 0.3 
1.5 ± 0.2 
- 
 
ND 
ND 
- 
Niacin (NE) 
Baseline 
Intervention 
Supplement 
 
18 ± 1.0 
23 ± 9 
20 
 
24 ± 2.9 
26 ± 7 
- 
 
22 ± 2.0 
25 ± 2 
- 
 
20 ± 1.2 
23 ± 5 
- 
 
13 ± 2.9 
17 ± 6 
- 
 
ND 
ND 
- 
Vitamin B6 (mg) 
Baseline 
Intervention 
Supplement 
 
1.3 ± 0.2 
3.1 ± 0.6 
1 
 
1.5 ± 0.3 
2.5 ± 0.6 
- 
 
1.6 ± 0.5 
3.3 ± 0.5 
- 
 
1.5 ± 0.3 
2.5 ± 0.4 
- 
 
1.9 ± 1.5 
1.8 ± 0.2 
- 
 
ND 
ND 
- 
Vitamin B12 (µg) 
Baseline 
Intervention 
Supplement 
 
3.5 ± 0.5 
4.3 ± 0.4 
3(MV) + 1200 
 
4.4 ± 0.4 
5.5 ± 0.7 
- 
 
4.4 ± 0.3 
5.7 ± 0.8 
- 
 
3.5 ± 0.5 
4.7 ± 0.7 
- 
 
1.7 ± 0.7 
3.0 ± 0.4 
- 
 
ND 
ND 
- 
Vitamin C (mg) 
Baseline 
Intervention 
Supplement 
 
139 ± 113 
229 ± 28 
50 
 
209 ± 72 
318 ± 52 
- 
 
208 ± 53 
267 ± 25 
- 
 
183 ± 105 
208 ± 69 
- 
 
226 ± 92 
177 ± 24 
- 
 
ND 
ND 
- 
Vitamin D (µg) 
Baseline 
Intervention 
Supplement 
 
0.5 ± 0.4 
9.5 ± 3.1 
10 
 
5.8 ± 0.7 
14 ± 2.8 
- 
 
3.9 ± 2.2 
13 ± 1.8 
- 
 
3.2 ± 0.7 
12 ± 0.7 
- 
 
0.2 ± 0.04 
7.1 ± 1.3 
- 
 
ND 
ND 
- 
Folate (µg DFE) 
Baseline 
Intervention 
Supplement 
 
105 ± 26 
485 ± 110 
- 
 
189 ± 63 
528 ± 126 
- 
 
166 ± 15 
568 ± 50 
- 
 
105 ± 14 
491 ± 43 
- 
 
118 ± 104 
426 ± 74 
- 
 
ND 
ND 
- 
Pantothenic Acid (mg) 
Baseline 
Intervention 
Supplement 
 
2.9 ± 0.2 
5.0 ± 1.0 
- 
 
4.7 ± 1.0 
6.7 ± 1.1 
- 
 
4.5 ± 0.5 
6.7 ± 0.7 
- 
 
3.3 ± 0.3 
5.6 ± 0.5 
- 
 
2.2 ± 1.2 
4.2 ± 0.5 
- 
 
ND 
ND 
- 
Abbreviations: DFE, dietary folate equivalent; NE, niacin equivalents; MV, multivitamin; ND, not determined. 
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 Table B1(b) Mean (±SD) vitamin intakes at baseline and 8 weeks after intervention from food and daily vitamin supplement intake per subject 
(subjects 7-10). 
 
 7 8 9 10 11 
Thiamin (mg) 
Baseline 
Intervention 
Supplement 
 
0.6 ± 0.28 
1.6 ± 0.1 
- 
 
0.7 ± 0.1 
1.7 ± 0.3 
- 
 
0.8 ± 0.2 
1.7 ± 0.01 
- 
 
0.6 ± 0.04 
1.3 ± 0.4 
3 
 
0.7 ± 0.07 
1.9 ± 0.3 
3 
Riboflavin (mg) 
Baseline 
Intervention 
Supplement 
 
0.8 ± 0.08 
2.2 ± 0.2 
- 
 
1.4 ± 0.4 
2.1 ± 0.2 
- 
 
1.1 ± 0.3 
2.2 ± 0.3 
- 
 
1.1 ± 0.2 
2.2 ± 0.3 
2.5 
 
0.9 ± 0.2 
2.1 ± 0.3 
2.5 
Niacin (NE) 
Baseline 
Intervention 
Supplement 
 
14 ± 1.8 
23 ± 2.8 
- 
 
18 ± 0.9 
23 ± 4 
- 
 
17 ± 3.3 
22 ± 4.0 
- 
 
26 ± 4.9 
31 ± 2.7 
20 
 
14 ± 2.0 
21 ± 2.8 
20 
Vitamin B6 (mg) 
Baseline 
Intervention 
Supplement 
 
1.2 ± 0.5 
2.7 ± 0.2 
- 
 
1.9 ± 1.1 
2.9 ± 0.4 
- 
 
1.5 ± 0.5 
3.0 ± 0.6 
- 
 
1.4 ± 0.4 
2.6 ± 0.5 
1 
 
1.8 ± 0.9 
2.8 ± 0.4 
1 
Vitamin B12 (µg) 
Baseline 
Intervention 
Supplement 
 
2.4 ± 0.9 
5.1 ± 1.1 
- 
 
3.6 ± 1.3 
4.8 ± 0.9 
- 
 
2.8 ± 0.3 
4.9 ± 1.1 
- 
 
5.1 ± 0.8 
7.7 ± 0.9 
3 
 
2.7 ± 0.2 
5.0 ± 1.4 
3 
Vitamin C (mg) 
Baseline 
Intervention 
Supplement 
 
94 ± 53 
177 ± 24 
- 
 
112 ± 30 
231 ± 76 
- 
 
171 ± 36 
279 ± 82 
- 
 
63 ± 39 
148 ± 74 
50 
 
110 ± 10 
200 ± 47 
50 
Vitamin D (µg) 
Baseline 
Intervention 
Supplement 
 
0.4 ± 0.1 
13 ± 3.9 
- 
 
0.6 ± 0.3 
14 ± 3.9 
- 
 
1.2 ± 1.1 
13 ± 3.3 
- 
 
4.8 ± 0.7 
14 ± 2.5 
10 
 
0.5 ± 0.3 
12 ± 4.2 
10 
Folate (µg DFE) 
Baseline 
Intervention 
Supplement 
 
81 ± 43 
520 ± 64 
- 
 
126 ± 27 
565 ± 36 
- 
 
106 ± 34 
501 ± 54 
- 
 
45 ± 20 
424 ± 146 
- 
 
92 ± 77 
547 ± 59 
- 
Pantothenic Acid (mg) 
Baseline 
Intervention 
Supplement 
 
2.1 ± 0.3 
5.7 ± 0.2 
- 
 
3.3 ± 0.3 
6.0 ± 0.9 
- 
 
2.8 ± 0.9 
5.7 ± 0.7 
- 
 
3.2 ± 1.1 
6.3 ± 0.7 
- 
 
2.0 ± 0.1 
5.2 ± 1.0 
- 
Abbreviations: DFE, dietary folate equivalent; NE, niacin equivalents; ND, not determined.
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APPENDIX C 
Research Ethics Board and Saskatoon Health Region Confirmation of Approval 
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APPENDIX D 
Participant Consent Forms for Sensory Testing and Fortification Trial
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Participant Information and Consent Form (University Staff and Students)    
March 09, 2006 
 
Study Title: Development and Commercialization of Pulse-based and Nutrient -Fortified Pureed 
Foods  
 
Principle Investigator: Dr. W. Dahl, Adjunct Professor, College of Pharmacy and Nutrition 
 
Sub-investigator: Dr. R. Tyler, Professor and Associate Dean (Academics), College of 
Agriculture. 
 
Funded by: Saskatchewan Pulse Growers and the NRCC Industrial Research Assistance  
Program. 
  
Assisting with this study may help to develop new, nutrient-dense pureed foods. If you are a 
student, staff or faculty member at the University of Saskatchewan, and you decide not to 
participate or to later withdraw your consent, your decision will not affect your academic 
standing, employment, promotion or the services you could otherwise expect to receive at the 
University. 
 
Participation in this study is voluntary and you have the right to refuse participation or if you 
volunteer, to withdraw from the study at anytime. If you do not wish to participate, you do not 
have to provide any reason for your decision nor will you lose the benefit of any medical care to 
which you are entitled or are presently receiving. 
 
Purpose of the Study: 
 
The purpose of this study is to determine the sensory acceptability of pulse-based and nutrient-
fortified pureed foods. 
 
Benefits:  There may be no direct benefit for participating in this study.  
 
Procedures: 
 
1. You will be asked to participate in a maximum of five, 20 minute sensory (taste-testing) 
sessions where you will sample a variety of pulse-based or nutrient-fortified pureed foods on 
several different days.  You will be asked to taste three foods per session. If there are any 
foods that you do not want to sample, you can decline to do so. 
 
2. You will be asked evaluate the aroma, taste, mouth-feel, ease of swallowing and general 
acceptability of the pureed foods. A written questionnaire will be used to record sensory 
characteristics. 
 
Sensory evaluation will be carried out in the Sensory Laboratory, College of Agriculture.  
 
Confidentiality:  
 
While absolute confidentiality cannot be guaranteed, every effort will be made to ensure that the  
information you provide for this study is kept entirely confidential. Your name will not be attached 
to any information, nor mentioned in any study report, nor be made available to anyone except  
the research team.  
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Participation is Voluntary: 
 
Your participation in this study is entirely voluntary. You have the right to refuse participation and 
to withdraw from the study at any time, for any reason. Early withdrawal from the study will not 
result in any sort of penalty.  
 
Potential Risks: 
 
There are no foreseen risks associated with study. Individuals with food allergies will not be able 
to participate in this study. As with any intervention, there may be unforeseen risks.    
 
Research Related Injury: 
 
There will be no costs to you for your participation in this study. You will not be charged for any 
research procedures. In the event that you become ill or injured as a result of participating in this 
study, necessary medical treatment will be made available at no cost to you. 
 
Compensation 
  
Sensory participants will be provided with $5.00 University of Saskatchewan Bookstore gift 
certificates for each sensory session. 
 
Contacts:  
 
If you have any questions with regards to this research project, please do not hesitate to contact 
the researchers below: 
 
Dr. Wendy Dahl  655 1310 
Dr. Robert Tyler 966 4064 
 
This study has been approved, on ethical grounds, by the Biomedical Research Ethics Board 
(Bio-REB) of the University of Saskatchewan. If you have any questions about your rights as a 
research subject, you may contact the chair of the Biomedical Ethics Board, c/o the Office of 
Research Services, University of Saskatchewan at (306) 966 4053. 
  
The contents of this consent form have been explained to me. I have been able to ask questions 
about the study and these questions have been answered to my satisfaction. I have received a 
copy of the consent form for my own records. I freely consent to participate in this study. I am 
not waiving any of my legal rights by signing this consent form. 
 
Do you have a food allergy?      ____ yes ____no 
 
SIGNATURES 
 
Study Volunteer: _________________________Date: __________________ 
 
Research Coordinator: ____________________ Date: __________________ 
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Participant Information and Consent Form                                  November 28, 2006  
 
Study Title:  Effect of fortified pureed foods on nutrient intakes and serum vitamin 
levels in long-term care residents. 
 
Principal Investigator: Dr. Wendy J. Dahl is investigating the effect of vitamin fortification 
of pureed food on nutrient intakes and serum levels of vitamins in long-term care 
residents on a pureed diet. 
Wendy Dahl RD PhD, Adjunct Professor 
College of Pharmacy and Nutrition, University of Saskatchewan 
110 Science Place, Saskatoon, SK, S7N 5C9 
 
Sub-investigators: Dr. Susan Whiting, Professor and Jennifer Dunne, Graduate 
Student, College of Pharmacy and Nutrition, University of Saskatchewan. 
 
You are being asked to take part in this research because you are a resident in a long 
term care home and on a pureed diet. Participation in this study is voluntary and you 
have the right to refuse to participate. If you volunteer, you can withdraw from the study 
at anytime. If you do not wish to participate, you do not have to provide any reason for 
your decision, nor will you lose the benefit of any care to which you are entitled or are at 
present receiving.  
 
In this consent form “you” always refers to the patient. If you are an authorized 
representative, please remember that ‘you’ refers to the patient. An authorized 
representative in this study would be the person who is entrusted by a competent 
patient/subject to make all the decisions around the study for the patient provided the 
patient gives consent to the general understanding of the clinical trial and authorizes the 
representative to make ongoing decisions when he/she (the patient) cannot. 
 
Purpose of the Study: 
 
Residents of long term care homes have high nutritional needs, but often consume 
small amounts of food, particularly if they have swallowing problems and are on a 
pureed diet. The purpose of this study is to determine whether adding vitamins to usual 
pureed foods improves intake of vitamins as well as improving the nutritional status of 
those consuming the pureed foods.  
 
Benefits:  There may not be direct benefits to you for participating in this study. 
Knowledge gained from this study may help to improve nutritional care for long term 
care residents with swallowing disorders.  
 
Procedures: 
 
1. You will be required to provide 5 ml venous blood samples, two at the beginning 
of the study and two at the end of the study. A Certified Laboratory Technologist will 
collect the blood samples. Your blood samples will be tested for the levels of vitamin 
B12, folate and vitamin D.  
 
2. Your facility medical chart will be reviewed to determine what vitamin and 
mineral supplements you are currently prescribed. The chart review will be carried out 
by the research coordinator.  
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3. You will consume your regular pureed diet for eight weeks. However, some of 
the pureed foods will be have added vitamins.   
 
4. Your food intake will be measured for three days at the beginning of the study 
and three days at the end of the study. Food placed on your plate will be weighed 
before it is served. After you have eaten, any food remaining on your plate will be 
weighed once your plate is removed from the table. 
 
Care will be taken throughout the three days of the food intake weighing, that your 
meals will notbe delayed. Your time commitment for this study is estimated at about 
two hours, as it is expected that only the venous blood sample will take your time.   
 
Confidentiality:  
 
While absolute confidentiality cannot be guaranteed, every effort will be made to ensure 
that theinformation you provide for this study is kept entirely confidential. Your name 
will not be attached to any information, nor mentioned in any study report, nor be 
made available toanyone except the research team. It is possible that that the 
research team may wish to presentthe results of this study in scientific journals or at 
conferences and workshops, but your identity will not be revealed. 
 
Participation is Voluntary: 
 
Your participation in this study is entirely voluntary. You have the right to refuse to 
participate and to withdraw from the study at any time, for any reason. Early withdrawal 
from the study will not result in any sort of penalty.  
 
Potential Risks: 
 
The risk of drawing blood include: temporary discomfort from the needle stick, bruising 
and rarely, infection. 
 
Research Related Injury: 
 
There will be no costs to you for participation in this study. You will not be charged for 
any research procedures and participating in this study will not affect your care. In the 
event that you become ill or injured as a result of participating in this study, necessary 
medical treatment will be made available at no additional cost to you. 
 
Compensation:  
 
You will be provided $50 for participation in this research study. 
 
Contacts:  
 
If you have any questions with regards to this research project, please do not hesitate 
to contact the researchers below: 
 
Jennifer Dunne  (306) 717 1848 
Wendy Dahl   (306) 655 1310 
Susan Whiting   (306) 966 5837 
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This study has been approved, on ethical grounds, by the Biomedical Research Ethics 
Board (Bio-REB) of the University of Saskatchewan. If you have any questions about 
your rights as a research subject, you may contact the chair of the Biomedical Ethics 
Board, c/o the Ethics Office, University of Saskatchewan at (306) 966 4053. 
 
The contents of this consent form have been explained to me. I have been able to ask 
questions about the study and these questions have been answered to my satisfaction. 
I have received a copy of the consent form for my own records. I freely consent to 
participate in this study. I am not waiving any of my legal rights by signing this consent 
form.  
 
SIGNATURES 
 
Participant: ___________________________________ Date: __________________ 
 
Authorized Representative _______________________ Date: __________________ 
 
Relationship of the Authorized Representative to the Participant: __________________ 
 
Research Coordinator: __________________________ Date: __________________ 
 
 
 
 
